Hypertrophy of breast

N14_HYPERTROPHYBREAST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N62 Hospital discharge: ICD-9 — 6111 Hospital discharge: ICD-8 — 6111 Cause of death: ICD-10 — N62 Cause of death: ICD-9 — 6111 Cause of death: ICD-8 — 6111 2 out of 7 registries used, show all original rules.	8693
4. Check minimum number of events None	8693
5. Include endpoints None	8693
6. Filter based on genotype QC (FinnGen only)	7895

Control definitions (FinnGen only)

Control exclude: N14_BREAST

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N60-N64
Name in latin: Hypertrophia mammae

NAME	N14_HYPERTROPHYBREAST
CONTROL_EXCLUDE	N14_BREAST
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N62
HD_ICD_9	6111
HD_ICD_8	6111
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N62
COD_ICD_9	6111
COD_ICD_8	6111
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypertrophy of breast based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36263	36263	-
Only index persons	35559	35559	-
Unadjusted period prevalence (%)
Whole population	1.04	1.04	-
Only index persons	1.31	1.31	-
Median age at first event (years)
Whole population	-	47.16	-
Only index persons	-	47.16	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7895	7895	-
Unadjusted period prevalence (%)	2.80	2.80	-
Median age at first event (years)	49.01	49.01	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8203: Matched controls
82030

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

16.4

315.1

268

169

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.1

307.7

1658

3902

ZXA10

NOMESCO Finland

Bilateral

4.4

307.7

2690

8209

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

19.0

307.7

271

147

HA1AA

NOMESCO Finland

X-ray mammography

4.5

307.7

1779

4710

9722

FHL

Reduction plastic and possible mamilla transposition

204.2

307.7

238

6111A

ICD-9 Finland

Other disorders of breast, Hypertrophy of breast

+∞

307.7

315

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

9.4

307.7

998

1185

N62

ICD-10 Finland

Hypertrophy of breast

18801.7

307.7

7832

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

309.9

307.7

5678

591

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

11.7

286.2

296

261

X21

ICPC

Breast sympt/compl female other

5.6

266.1

525

988

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

248.3

2332

11709

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

246.2

1329

5090

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

13.0

244.8

237

188

HAD99

NOMESCO Finland

Other plastic operation on breast

12.4

236.8

235

194

HAD35

NOMESCO Finland

Reduction mammoplasty with transplantation of areola

81.9

227.9

121

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

227.9

3341

19981

N63

ICD-10 Finland

Unspecified lump in breast

3.4

226.3

876

2752

WX402

NOMESCO Finland

General anaesthesia

2.2

210.6

2447

13284

QBJ30

NOMESCO Finland

Correction of abdominal apron

8.1

209.0

284

361

ZXE20

NOMESCO Finland

More than three and less than five hours

2.7

189.3

1215

5047

S18

ICPC

Laceration/cut

1.9

171.3

3994

27293

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

155.6

2307

13457

HAE99

NOMESCO Finland

Other reconstruction of breast

7.6

147.7

211

284

N02AX02

ATC

tramadol; systemic, rectal

1.8

146.9

3632

24888

N02BE01

ATC

paracetamol; systemic, rectal

3.3

146.1

7731

68405

QBJ00

NOMESCO Finland

Liposuction in trunk

9.9

145.3

167

171

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

144.8

3924

27601

HAC20

NOMESCO Finland

Total mastectomy

3.2

139.6

578

1877

N64.9

ICD-10 Finland

Disorder of breast, unspecified

10.1

139.5

159

161

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

138.9

1304

6369

J01DB01

ATC

cefalexin; oral

2.2

131.0

7125

61315

115

Kela drug reimbursment

Breast cancer

2.3

128.2

1104

5189

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

13.4

125.4

118

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.9

123.7

628

2289

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

5.1

123.5

266

538

E66.8

ICD-10 Finland

Other obesity

2.5

123.3

822

3441

M03BX02

ATC

tizanidine; oral

1.8

122.2

5829

47261

N61

ICD-10 Finland

Inflammatory disorders of breast

4.4

120.3

306

710

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.7

117.9

691

2713

N64.8

ICD-10 Finland

Other specified disorders of breast

11.1

117.0

124

113

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.0

115.8

336

861

N06AX16

ATC

venlafaxine; oral

1.9

109.9

1643

9452

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

3.8

108.6

343

933

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

4.7

107.6

255

559

A02BC02

ATC

pantoprazole; systemic

1.7

106.0

5808

47838

HAD20

NOMESCO Finland

Liposuction of breast

17.5

104.1

N64.5

ICD-10 Finland

Other signs and symptoms in breast

4.2

104.0

283

691

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.6

102.9

621

2470

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

9.8

102.8

119

123

G47.3

ICD-10 Finland

Sleep apnoea

1.8

100.3

1822

11113

M79.6

ICD-10 Finland

Pain in limb

1.6

99.6

4164

31748

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.7

98.3

570

2221

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

98.2

3775

28156

TQW20

NOMESCO Finland

Tatoe

4.7

96.6

224

482

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

92.2

3093

22200

N06AX21

ATC

duloxetine; oral

1.9

92.0

1318

7434

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.6

91.5

147

225

ZZF00

NOMESCO Finland

Graft of adipose tissue

5.6

90.9

175

320

TQW40

NOMESCO Finland

Remowal of suture of skin

2.4

89.5

690

3071

N06AB10

ATC

escitalopram; oral

1.7

89.3

2136

14025

R03AC02

ATC

salbutamol; inhalant

1.6

88.8

5000

40468

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

86.2

627

2718

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

86.0

6239

53518

N06AX11

ATC

mirtazapine; oral

1.6

86.0

3064

22216

A02BC05

ATC

esomeprazole; systemic

1.6

85.8

3523

26408

61110

ICD-8 Finland

Other diseases of breast, Hyperplasia mammae

+∞

85.6

N05CF02

ATC

zolpidem; oral

1.8

85.3

1719

10741

N03AX16

ATC

[U] pregabalin

1.7

84.8

1968

12788

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

84.7

3442

25711

M01AH05

ATC

etoricoxib; oral

1.6

83.5

5620

47090

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.7

82.4

463

1772

M01AB05

ATC

diclofenac; systemic, rectal

1.6

81.9

5608

47058

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.3

81.5

685

3160

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

4.9

81.4

182

380

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

3.5

81.3

288

845

C50.99

ICD-10 Finland

Breast, unspecified

3.1

80.6

356

1196

N05CF01

ATC

zopiclone; oral

1.6

76.5

2506

17689

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

6.1

76.5

134

224

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

76.1

2072

13976

G44.2

ICD-10 Finland

Tension-type headache

1.8

75.3

1491

9232

N64.4

ICD-10 Finland

Mastodynia

2.6

72.3

441

1757

N05BA04

ATC

oxazepam; oral

1.6

72.2

2315

16214

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

72.0

2243

15599

SPAT1153

SPAT

Removal of sutures

1.6

71.7

2280

15932

M01AE01

ATC

ibuprofen; systemic, rectal

2.3

70.7

7733

71849

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

70.4

2153

14892

M54.5

ICD-10 Finland

Low back pain

1.5

69.6

3333

25474

J02AC01

ATC

fluconazole; systemic

1.5

67.0

4343

35229

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

66.9

2776

20530

N03AX12

ATC

[U] gabapentin; oral

1.7

66.9

1366

8503

R51.80

ICD-10 Finland

Headache

1.7

65.8

1577

10244

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.4

65.2

235

697

M25.5

ICD-10 Finland

Pain in joint

1.5

64.9

3183

24339

N06AB04

ATC

citalopram; systemic

1.6

64.6

1855

12598

X76

ICPC

Malignant neoplasm breast female

3.1

63.7

275

911

E66.9

ICD-10 Finland

Obesity, unspecified

2.5

63.4

424

1764

B01AB05

ATC

enoxaparin; parenteral

1.5

63.3

2407

17422

H02.3

ICD-10 Finland

Blepharochalasis

2.1

62.5

617

3026

J01FF01

ATC

clindamycin; systemic

1.6

62.1

2159

15308

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

61.9

2201

15680

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

61.8

1395

8903

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

61.0

937

5353

Z3226

NOMESCO Finland

Physiotherapist

1.7

60.9

1388

8878

M01AE02

ATC

naproxen; oral, rectal

1.5

60.9

4932

41453

L02BA01

ATC

tamoxifen; oral

2.3

60.2

487

2204

R4110

NOMESCO Finland

Physiotherapy

1.5

59.7

2138

15232

E66

ICD-10 Finland

Obesity

2.0

59.6

671

3453

Z3231

NOMESCO Finland

Registered nurse

1.6

59.6

1982

13890

PJA12

NOMESCO Finland

Sentinel node biopsy

1.9

59.4

858

4807

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

6.5

59.0

149

R5140

NOMESCO Finland

Monitoring the use of the aid

1.9

58.5

786

4299

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

58.0

2797

21185

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

3.3

57.8

227

711

ZXA00

NOMESCO Finland

Right side

1.6

57.2

1793

12378

L91.0

ICD-10 Finland

Hypertrophic scar

3.7

57.0

180

489

A02BC03

ATC

lansoprazole; oral

1.5

56.1

2201

15956

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

2.7

55.7

310

1179

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

55.6

1709

11736

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

55.0

6284

55925

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

54.8

2432

18068

P01AB01

ATC

metronidazole; oral, rectal

1.4

54.6

3721

30003

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

54.3

1664

11410

9723

FHL

Reducing plastic mom

278.2

54.2

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

54.2

1249

7990

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

53.9

1096

6781

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

53.5

3053

23792

J01AA02

ATC

doxycycline; systemic

1.5

53.1

6437

57710

NK6AN

NOMESCO Finland

Total body bone isotope imaging

3.3

53.1

203

625

N06AB03

ATC

fluoxetine; oral

1.7

53.0

1140

7158

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

52.8

4833

41011

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

17.3

52.3

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

52.3

3167

24926

N05AH04

ATC

quetiapine; oral

1.6

51.8

1482

9990

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.7

51.3

165

454

X22

ICPC

Concern breast appearance fema

16.6

51.3

N06AX12

ATC

bupropion; oral

1.9

51.1

754

4243

L02BG04

ATC

letrozole; oral

1.8

50.7

774

4401

HAB99

NOMESCO Finland

Other partial excision of mammary gland

2.8

50.7

252

903

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

3.2

50.5

206

660

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

3.7

50.3

160

437

J01FA10

ATC

azithromycin; systemic

1.4

50.3

5198

44885

R06.0

ICD-10 Finland

Dyspnoea

1.5

50.2

1980

14309

ZXE00

NOMESCO Finland

One hour or less

1.4

50.1

3034

23821

WX702

NOMESCO Finland

Supraglottic ventilation device

2.1

49.8

520

2600

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

49.3

1238

8078

A02BC01

ATC

omeprazole; systemic

1.5

49.1

2030

14805

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

48.9

755

4308

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

48.8

2440

18467

HAD40

NOMESCO Finland

Mastopexy

5.2

48.8

100

194

L03

ICPC

Low back symptom/complaint

1.4

48.7

2597

19890

R03DC03

ATC

montelukast; oral

1.5

48.6

1598

11096

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

48.3

775

4472

M79.1

ICD-10 Finland

Myalgia

1.6

48.2

1421

9628

T82

ICPC

Obesity

2.1

48.0

507

2546

L15

ICPC

Knee symptom/complaint

1.5

47.9

2186

16241

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

47.7

5034

43409

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

46.7

1603

11225

J01DA01

ATC

[U] cefalexin

1.4

46.6

5033

43482

S21.0

ICD-10 Finland

Open wound of breast

18.6

46.5

H02AB06

ATC

prednisolone; systemic

1.4

45.9

3730

30680

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

2.2

45.6

418

1988

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

45.3

903

5542

N06AA09

ATC

amitriptyline; systemic

1.8

45.2

776

4566

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

45.0

3880

32191

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

45.0

1686

12017

J01MA02

ATC

ciprofloxacin; systemic

1.4

44.9

2636

20476

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

44.8

1173

7714

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

44.7

273

1087

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

2.8

44.6

232

852

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

44.5

1954

14374

N60.2

ICD-10 Finland

Fibroadenosis of breast

7.6

44.5

M01AH01

ATC

celecoxib; oral

1.5

44.2

1418

9771

ZXD20

NOMESCO Finland

Day surgery

1.6

44.1

1026

6554

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

43.2

848

5179

M01AX17

ATC

nimesulide; oral

1.5

43.1

1695

12184

M79.7

ICD-10 Finland

Fibromyalgia

2.0

43.1

458

2304

L01

ICPC

Neck symptom/complaint

1.5

43.0

1538

10841

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

42.9

2035

15176

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

42.7

1566

11097

R01AD58

ATC

fluticasone, combinations; nasal

1.4

42.6

2467

19076

WZC30

NOMESCO Finland

Teaching

1.6

42.6

1206

8074

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

42.6

3498

28697

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

42.3

725

4260

M54.2

ICD-10 Finland

Cervicalgia

1.8

42.3

746

4420

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

42.1

2530

19684

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

2.3

41.9

313

1367

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.0

41.9

190

648

R03BA05

ATC

fluticasone; inhalant

1.5

41.8

1541

10923

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

41.6

1281

8735

R01AD08

ATC

fluticasone; nasal

1.4

41.4

2508

19527

ZXA05

NOMESCO Finland

Left side

1.5

41.1

1574

11243

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

40.7

412

2035

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

40.5

1500

10636

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

40.5

3300

26966

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.1

40.4

168

545

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

40.4

601

3384

C50

ICD-10 Finland

Malignant neoplasm of breast

2.4

40.3

280

1184

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

40.1

1796

13223

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

40.0

3941

33162

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

39.9

1053

6926

M48.0

ICD-10 Finland

Spinal stenosis

1.7

39.7

743

4472

UJF32

NOMESCO Finland

Coloscopy

1.5

39.7

1810

13364

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

5.3

39.7

153

SFA10

NOMESCO Finland

One-surface restoration

1.4

39.4

4658

40275

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

39.3

854

5350

M01AC06

ATC

meloxicam; systemic, rectal

1.4

39.3

2926

23528

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

39.0

4626

39989

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

38.8

744

4509

G04BD12

ATC

mirabegron; oral

1.7

38.8

787

4843

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

38.7

2659

21086

WX704

NOMESCO Finland

Intubation

1.8

38.7

671

3952

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

8.1

38.4

HAC30

NOMESCO Finland

Excision of supernumerary mammary gland or mamilla

14.8

38.2

R01AD12

ATC

fluticasone furoate; nasal

1.4

38.2

2946

23795

R53

ICD-10 Finland

Malaise and fatigue

1.4

38.2

2030

15403

N02BF01

ATC

gabapentin; oral

1.6

38.2

904

5788

WX290

NOMESCO Finland

Other blockage of nerve

1.4

38.1

4106

34917

L17

ICPC

Foot/toe symptom/complaint

1.4

38.1

2485

19527

L13

ICPC

Hip symptom/complaint

1.5

38.0

1594

11571

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

37.9

808

5037

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

37.7

1371

9670

R01AD09

ATC

mometasone; nasal

1.3

37.6

4055

34461

P06

ICPC

Sleep disturbance

1.5

37.6

1158

7883

SFA20

NOMESCO Finland

Two-surface restoration

1.4

37.5

5012

43994

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

37.4

1228

8475

Z01.2

ICD-10 Finland

Dental examination

1.3

37.3

4104

34964

J45

ICD-10 Finland

Asthma

1.6

37.0

954

6231

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

36.8

5781

51966

R03BA02

ATC

budesonide; inhalant

1.5

36.8

1509

10897

R06AX27

ATC

desloratadine; oral

1.4

36.6

2745

22031

R42

ICD-10 Finland

Dizziness and giddiness

1.4

36.4

1682

12422

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

36.2

504

2776

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

36.2

3550

29677

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

36.1

622

3656

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

36.0

1110

7552

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

36.0

2560

20361

C09CA06

ATC

candesartan; oral

1.4

36.0

1924

14588

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

35.8

204

786

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

35.5

1053

7100

R06AE07

ATC

cetirizine; oral

1.3

35.4

3888

33017

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

35.1

2031

15597

N06AB06

ATC

sertraline; oral

1.6

35.0

1007

6745

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

34.9

1471

10668

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

34.7

778

4906

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

34.6

4296

37088

N81.6

ICD-10 Finland

Rectocele

1.7

34.4

684

4182

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.0

34.4

157

538

A04AA02

ATC

granisetron; systemic, transdermal

1.9

34.3

488

2706

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

34.2

2299

18088

K02.1

ICD-10 Finland

Caries of dentine

1.3

34.1

4911

43272

SPAT1263

SPAT

Sampling

1.3

33.7

3130

25865

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

33.7

911

6011

H03AA01

ATC

levothyroxine sodium; systemic

1.4

33.5

2134

16630

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

4.3

33.4

198

Z71.8

ICD-10 Finland

Other specified counselling

1.3

33.1

2865

23409

X58

ICD-10 Finland

Exposure to other specified factors

1.5

32.9

1098

7588

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

32.6

995

6744

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

32.6

1006

6837

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

32.5

1472

10803

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

32.3

847

5545

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

32.3

786

5055

N06AX26

ATC

vortioxetine; oral

1.7

32.0

683

4251

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

5.0

31.8

137

F32

ICD-10 Finland

Depressive episode

1.8

31.8

529

3076

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.6

31.7

185

721

K30

ICD-10 Finland

Functional dyspepsia

1.5

31.7

1009

6899

N01

ICPC

Headache

1.5

31.7

1065

7367

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

31.6

997

6805

D24

ICD-10 Finland

Benign neoplasm of breast

2.6

31.3

183

714

G04BD04

ATC

oxybutynin; oral, transdermal

2.0

31.3

356

1834

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

31.2

1869

14390

WX723

NOMESCO Finland

CPAP therapy

2.0

31.2

338

1711

C07AB07

ATC

bisoprolol; oral

1.3

31.1

2885

23759

P03

ICPC

Feeling depressed

1.5

31.1

965

6562

T83

ICPC

Overweight

2.2

31.0

270

1258

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

31.0

601

3647

L08

ICPC

Shoulder symptom/complaint

1.4

31.0

1818

13950

A08AA02

ATC

fenfluramine; oral

3.7

30.9

268

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

30.8

828

5451

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

30.7

364

1902

H02AB02

ATC

dexamethasone; systemic

1.6

30.4

866

5777

WX780

NOMESCO Finland

Remote monitoring CPAP

2.0

30.3

334

1701

J01FA09

ATC

clarithromycin; systemic

1.3

30.2

2621

21353

C07AA05

ATC

propranolol; systemic

1.4

30.2

1741

13310

A10BA02

ATC

metformin; oral

1.4

30.0

1582

11912

SPAT1310

SPAT

Counselling related to known health issue

1.3

30.0

2284

18247

A02BA02

ATC

ranitidine; systemic

1.5

29.9

1231

8862

XX3DW

NOMESCO Finland

Time consuming IT work

1.6

29.7

710

4543

TQB05

NOMESCO Finland

Puncture of skin of trunk

3.3

29.7

111

338

L02

ICPC

Back symptom/complaint

1.5

29.6

929

6328

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

29.4

800

5278

A02BC04

ATC

rabeprazole; oral

1.6

29.4

745

4835

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

2.9

29.3

134

460

L12

ICPC

Hand/finger symptom/complaint

1.4

29.2

1454

10831

61000

ICD-8 Finland

Chronic cystic disease of breast, Fibroadenomatosis mammae

+∞

29.2

J01MA12

ATC

levofloxacin; systemic

1.5

29.2

1102

7798

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

29.2

685

4365

SFA30

NOMESCO Finland

Three-surface restoration

1.3

29.1

3392

28753

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

2.3

29.1

220

967

UKC02

NOMESCO Finland

Cystoscopy

1.6

29.0

665

4211

C10AA07

ATC

rosuvastatin; oral

1.3

29.0

2364

19061

M54

ICD-10 Finland

Dorsalgia

1.5

29.0

1067

7512

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

28.9

352

1856

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

28.7

2443

19811

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

9.0

28.6

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

28.4

959

6630

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

28.4

1831

14233

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.3

28.4

105

318

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

28.4

243

1125

A87

ICPC

Complication of medical treatment

4.1

28.3

193

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

28.3

674

4308

L02BG03

ATC

anastrozole; oral

2.7

28.3

155

586

9729

FHL

Other measure in this category

9.2

28.2

N05BA01

ATC

diazepam; systemic, rectal

1.5

28.1

895

6111

ZZR10

NOMESCO Finland

Flap of skin and muscle

3.5

28.1

267

HA1HA

NOMESCO Finland

Tomosynthesis mammography

3.4

28.0

102

306

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

28.0

1201

8704

G04BD08

ATC

solifenacin; oral

1.8

27.9

405

2259

R05

ICPC

Cough

1.3

27.7

2069

16441

HAA10

NOMESCO Finland

Biopsy of mammary gland

4.2

27.7

175

L90.6

ICD-10 Finland

Striae atrophicae

5.5

27.6

L02BG06

ATC

exemestane; oral

2.4

27.6

196

839

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

27.5

296

1494

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

27.5

3113

26219

M01AX05

ATC

glucosamine; oral

1.5

27.5

1142

8224

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

27.5

2466

20123

AA1AD

NOMESCO Finland

CT of head and brain

1.4

27.5

1659

12754

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

1.9

27.3

382

2108

A01

ICPC

Pain general/multiple sites

1.5

27.2

787

5263

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

27.1

447

2590

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

27.0

2105

16822

R03BA01

ATC

beclometasone; inhalant

1.5

27.0

1087

7778

WX002

NOMESCO Finland

Sedation and analgesia

1.4

27.0

1243

9121

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.8

26.9

393

2196

G54.0

ICD-10 Finland

Brachial plexus disorders

2.1

26.9

270

1329

R06.5

ICD-10 Finland

Mouth breathing

1.7

26.9

578

3601

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.6

26.9

719

4723

N02AA05

ATC

oxycodone; systemic

1.5

26.8

960

6713

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.1

26.8

243

1151

J01DA09

ATC

[U] cefadroxil

1.3

26.8

2056

16391

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

26.7

1409

10584

R05

ICD-10 Finland

Cough

1.4

26.7

1699

13163

HAD00

NOMESCO Finland

Augmentation mammoplasty

8.5

26.6

N60.8

ICD-10 Finland

Other benign mammary dysplasias

45.9

26.4

S29

ICPC

Skin symptom/complaint other

1.4

26.2

1520

11595

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.6

26.2

634

4068

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

2.5

26.2

161

645

WX320

NOMESCO Finland

Spinalanesthesy

1.4

26.1

1708

13282

R02

ICPC

Shortness of breath/dyspnoea

1.5

26.1

948

6647

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

+∞

26.0

R52.9

ICD-10 Finland

Pain, unspecified

1.5

26.0

822

5600

R74

ICPC

Upper respiratory infection acute

1.3

25.7

3089

26152

X18

ICPC

Breast pain female

2.4

25.7

179

759

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1.7

25.7

447

2631

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

25.6

891

6194

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

25.5

1115

8098

C03CA01

ATC

furosemide; systemic

1.4

25.4

1331

9978

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

2.8

25.4

128

464

ZXD05

NOMESCO Finland

Urgent procedure

1.3

25.4

2074

16664

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

25.3

3145

26725

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

25.3

1474

11246

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

25.3

1063

7664

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

2.5

25.2

156

627

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

25.2

971

6886

P01

ICPC

Feeling anxious/nervous/tense

1.4

25.1

1204

8890

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

2.3

25.1

200

900

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

25.0

426

2493

D07AC01

ATC

betamethasone; topical

1.3

25.0

2704

22565

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

24.9

680

4484

N05CD07

ATC

temazepam; oral

1.6

24.6

614

3965

L86

ICPC

Back syndrome with radiating pain

1.7

24.6

490

2991

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

24.6

430

2534

D82

ICPC

Teeth/gum disease

1.3

24.6

3147

26813

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

24.5

869

6058

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

24.5

305

1621

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

24.3

689

4581

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

3.2

24.3

298

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.4

24.2

1045

7567

R35

ICD-10 Finland

Polyuria

1.9

24.2

332

1821

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

24.0

4432

39439

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

3.5

23.9

237

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

23.9

1296

9766

J01FA06

ATC

roxithromycin; oral

1.3

23.7

3058

26041

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

23.7

326

1788

M02AA07

ATC

piroxicam; topical

1.3

23.7

2472

20492

K08.80

ICD-10 Finland

Toothache NOS

1.5

23.7

837

5830

L16

ICPC

Ankle symptom/complaint

1.4

23.6

993

7152

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

23.6

714

4817

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

4.4

23.5

132

A04

ICPC

Weakness/tiredness general

1.4

23.5

1171

8695

XKD00

NOMESCO Finland

Uroflowmetry

1.9

23.4

305

1644

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

23.3

499

3104

Z00.0

ICD-10 Finland

General medical examination

1.4

23.2

1315

9973

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

2.6

23.0

133

517

R4110, ,

SPAT

1.4

23.0

1025

7458

SPAT1240

SPAT

Therapeutic discussion

1.5

23.0

879

6217

R03AC03

ATC

terbutaline; inhalant

1.4

22.9

1100

8111

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.4

22.8

933

6683

SPAT1211

SPAT

Application of soft bandage

1.6

22.8

563

3626

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.9

22.7

303

1647

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

22.7

474

2931

H02AB04

ATC

methylprednisolone; systemic

1.4

22.6

1076

7921

SPAT1301

SPAT

No procedures

1.3

22.6

2058

16739

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

22.6

1997

16178

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.6

22.5

538

3438

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

22.4

1452

11241

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

4.3

22.4

133

ACC51

NOMESCO Finland

Release of median nerve

1.5

22.4

638

4246

9702

FHL

Breast exploration and possible tumor removal

3.6

22.3

200

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.1

22.3

226

1118

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

22.3

394

2330

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

22.2

1196

8989

R07.3

ICD-10 Finland

Other chest pain

1.5

22.2

710

4844

D01

ICPC

Abdominal pain/cramps general

1.4

22.2

1034

7584

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

22.0

892

6380

J01CA04

ATC

amoxicillin; systemic

1.3

21.9

6700

63105

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

21.9

520

3319

C03AA03

ATC

hydrochlorothiazide; oral

1.6

21.7

491

3096

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

21.7

653

4398

R52.2

ICD-10 Finland

Other chronic pain

1.8

21.7

300

1650

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

3.0

21.6

309

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

21.6

376

2213

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

21.5

855

6090

S06.0

ICD-10 Finland

Concussion

1.5

21.5

719

4950

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.6

21.5

475

2978

R01AD01

ATC

beclometasone; nasal

1.4

21.5

1220

9248

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

21.5

709

4869

P76

ICPC

Depressive disorder

1.5

21.5

623

4163

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

21.4

953

6929

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

21.4

2866

24438

M01AH02

ATC

rofecoxib; oral

1.5

21.4

788

5532

N02BF02

ATC

pregabalin; oral

1.6

21.3

541

3506

Q83.1

ICD-10 Finland

Accessory breast

5.9

21.3

N04BC05

ATC

pramipexole; oral

1.6

21.2

501

3192

N03AX09

ATC

lamotrigine; oral

1.7

21.2

413

2506

R06AX22

ATC

ebastine; oral

1.3

21.2

1512

11864

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

21.2

627

4206

N06AB05

ATC

paroxetine; oral

1.6

21.2

480

3029

K03.00

ICD-10 Finland

Approximal wear

1.5

21.1

617

4128

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

2.1

21.0

208

1021

R96

ICPC

Asthma

1.5

20.9

785

5527

A04AD12

ATC

aprepitant; systemic

2.1

20.9

194

929

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

20.9

875

6292

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

20.8

632

4262

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

20.8

700

4823

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

3.7

20.8

172

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

5.6

20.8

HAB30

NOMESCO Finland

Excision of mamilla or areola

24.2

20.8

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

20.7

436

2699

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

20.7

765

5373

D11

ICPC

Diarrhoea

1.4

20.6

999

7372

-1, ,

NOMESCO Finland

1.3

20.6

2567

21673

R21

ICPC

Throat symptom/complaint

1.3

20.6

1889

15345

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

1.8

20.6

298

1662

E0000UV, ,

ATC

1.3

20.5

3285

28549

N39.3

ICD-10 Finland

Stress incontinence

1.5

20.5

718

4987

N06BA04

ATC

methylphenidate; oral

1.9

20.5

270

1463

L04

ICPC

Chest symptom/complaint

1.6

20.4

487

3110

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

20.4

1180

8962

L28

ICPC

Limited function/disability (L)

1.4

20.4

1129

8515

J01CA08

ATC

pivmecillinam; oral

1.2

20.3

4200

37538

K07.60

ICD-10 Finland

Snapping jaw

1.6

20.3

513

3322

J05AB01

ATC

aciclovir; systemic

1.3

20.3

1766

14243

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

20.2

972

7159

L03AA13

ATC

pegfilgrastim; parenteral

1.7

20.2

366

2180

KMAK, ,

NOMESCO Finland

1.2

20.1

4124

36807

C10AA01

ATC

simvastatin; oral

1.3

20.0

1875

15266

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

19.9

1000

7419

N03AE01

ATC

clonazepam; systemic

1.7

19.9

388

2357

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.8

19.7

326

1892

J01EA01

ATC

trimethoprim; systemic

1.3

19.7

2211

18412

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

2.4

19.6

137

583

R83

ICPC

Respiratory infection other

1.3

19.6

2293

19185

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

4.9

19.6

T90

ICPC

Diabetes non-insulin dependent

1.3

19.5

1297

10058

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

7.7

19.5

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

5.1

19.5

R12

ICD-10 Finland

Heartburn

1.5

19.5

667

4611

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

19.4

830

5986

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

19.4

296

1677

N76.0

ICD-10 Finland

Acute vaginitis

1.5

19.3

697

4870

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

1.9

19.3

254

1376

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

19.3

178

851

A08AB01

ATC

orlistat; oral

3.6

19.2

177

OAA65, ,

SPAT

1.3

19.2

1831

14926

D07AD01

ATC

clobetasol; topical

1.3

19.2

1294

10054

R03BA08

ATC

ciclesonide; inhalant

1.5

19.2

714

5019

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

19.1

237

1259

C08CA01

ATC

amlodipine; oral

1.3

19.1

2090

17336

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

19.1

135

578

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.2

19.1

2870

24710

Z2221

NOMESCO Finland

Medical doctor

1.3

19.0

1976

16290

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

18.9

946

7010

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

18.9

301

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

18.9

1570

12565

M20.2

ICD-10 Finland

Hallux rigidus

1.9

18.9

242

1299

C10AA05

ATC

atorvastatin; oral

1.3

18.8

2315

19467

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

18.8

1647

13275

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

18.7

1581

12680

XKC03

NOMESCO Finland

Water cystometry

2.0

18.7

209

1072

N05BA12

ATC

alprazolam; oral

1.5

18.7

717

5069

F43.0

ICD-10 Finland

Acute stress reaction

1.5

18.6

592

4032

S80.0

ICD-10 Finland

Contusion of knee

1.5

18.5

647

4492

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.7

18.5

307

1784

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

18.5

616

4235

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

18.5

1730

14062

9703

FHL

Breast resection

4.1

18.4

123

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

2.2

18.4

155

715

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

18.4

468

3035

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

18.3

2950

25562

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

18.3

203

1039

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

18.2

275

1554

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

3.3

18.2

213

R60.0

ICD-10 Finland

Localized oedema

1.4

18.2

787

5686

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

4.5

18.2

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

18.2

471

3068

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

2.8

18.2

308

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.6

18.1

442

2838

H02AB07

ATC

prednisone; oral

1.4

18.1

911

6759

SPAT1312

SPAT

General health counselling

1.3

18.0

2243

18874

ZX080

NOMESCO Finland

Image guided radiotherapy

2.1

17.9

165

788

Z30.2

ICD-10 Finland

Sterilization

1.4

17.9

1031

7814

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

2.2

17.9

142

639

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

17.9

2039

16971

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

17.9

483

3175

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

17.8

210

1097

M54.8

ICD-10 Finland

Other dorsalgia

1.6

17.7

369

2279

HA1SA

NOMESCO Finland

Expansion mammography

3.8

17.7

140

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

+∞

17.7

N60.0

ICD-10 Finland

Solitary cyst of breast

4.5

17.7

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

3.7

17.7

154

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

17.7

452

2935

Q83.8

ICD-10 Finland

Other congenital malformations of breast

5.2

17.6

SPAT1260

SPAT

Consultation of another employee

1.3

17.6

1150

8884

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

17.6

196

1004

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

17.6

679

4803

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

2.8

17.6

308

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

17.6

756

5457

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.3

17.5

136

607

R13

ICD-10 Finland

Dysphagia

1.6

17.5

440

2846

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

1.9

17.5

220

1175

D06

ICPC

Abdominal pain localized other

1.4

17.4

742

5349

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

17.3

357

2200

SPAT1377

SPAT

Polysomnography

1.9

17.3

231

1258

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.6

17.3

418

2680

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

17.2

936

7029

L90

ICPC

Osteoarthrosis of knee

1.5

17.2

469

3090

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

17.1

760

5514

R06AE09

ATC

levocetirizine; oral

1.3

17.1

1185

9232

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

17.0

747

5410

RD211, ,

NOMESCO Finland

1.7

17.0

287

1676

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

16.8

458

3016

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

16.8

2760

23901

Z41.1

ICD-10 Finland

Other plastic surgery for unacceptable cosmetic appearance

3.1

16.8

219

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

16.8

210

1120

U02

ICPC

Urinary frequency/urgency

1.3

16.8

1211

9491

C05AA08

ATC

fluocortolone; rectal, topical

1.4

16.7

905

6790

SDA03

NOMESCO Finland

Periodontal treatment

1.2

16.7

3376

29867

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

2.2

16.6

144

672

WF003

NOMESCO Finland

Adjuvant radiotherapy

1.8

16.6

229

1259

D02

ICPC

Abdominal pain epigastric

1.5

16.6

509

3438

S04

ICPC

Lump/swelling localized

1.4

16.6

808

5955

JAH01

NOMESCO Finland

Laparoscopy

1.6

16.6

407

2617

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

16.6

218

1182

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.5

16.5

100

399

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

16.5

644

4563

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

16.5

784

5755

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

16.5

641

4539

N64.1

ICD-10 Finland

Fat necrosis of breast

170.3

16.5

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

1.8

16.5

253

1438

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

16.5

1821

15079

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

1.9

16.5

190

986

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

16.5

2294

19506

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

16.4

2212

18735

C07AB02

ATC

metoprolol; systemic

1.4

16.4

990

7552

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

16.4

727

5275

B02AA02

ATC

tranexamic acid; systemic

1.3

16.4

1530

12410

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

16.3

1083

8381

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.7

16.3

276

1613

R51

ICD-10 Finland

Headache

1.5

16.3

492

3314

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.3

16.3

122

537

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

3.1

16.2

213

X19

ICPC

Breast lump/mass female

2.0

16.2

172

867

F33

ICD-10 Finland

Recurrent depressive disorder

1.8

16.2

234

1306

M54.3

ICD-10 Finland

Sciatica

1.5

16.2

441

2905

M03AX01

ATC

botulinum toxin; parenteral

2.1

16.2

147

700

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

16.0

5259

48711

H57.1

ICD-10 Finland

Ocular pain

1.6

16.0

330

2033

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

16.0

592

4154

R00.2

ICD-10 Finland

Palpitations

1.4

15.9

675

4856

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

15.9

416

2715

EB1VA, ,

NOMESCO Finland

1.3

15.8

1429

11532

M77.4

ICD-10 Finland

Metatarsalgia

1.5

15.8

544

3763

UJH02

NOMESCO Finland

Anoscopy

1.7

15.8

280

1658

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

15.8

388

2497

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.8

15.8

124

N30.0

ICD-10 Finland

Acute cystitis

1.3

15.6

1494

12143

61099

ICD-8 Finland

Chronic cystic disease of breast, Unspecified

+∞

15.6

A99

ICPC

Disease/condition unspecnature/site

1.4

15.6

696

5052

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

15.6

685

4959

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

15.5

375

2404

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.4

15.5

699

5087

F34.1

ICD-10 Finland

Dysthymia

1.7

15.4

294

1777

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1.5

15.4

430

2849

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

15.4

369

2362

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

15.3

399

2601

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.6

15.3

357

2268

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

15.3

460

3096

N17

ICPC

Vertigo/dizziness

1.4

15.2

859

6482

A06AD11

ATC

lactulose; oral

1.4

15.2

693

5048

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

2.2

15.2

129

598

SCA02

NOMESCO Finland

Preventive oral health care

1.4

15.2

757

5600

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.8

15.2

238

1362

K04.08

ICD-10 Finland

Other specified pulpit

1.4

15.2

615

4390

D19

ICPC

Teeth/gum symptom/complaint

1.2

15.1

2539

21979

K03.80

ICD-10 Finland

Irradiated enamel

1.5

15.1

505

3473

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

15.1

442

2958

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

1.9

15.1

182

960

M01AC01

ATC

piroxicam; systemic, rectal

1.4

15.1

784

5841

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

15.1

1270

10154

SPAT1283

SPAT

Restricted health certificate

1.3

15.1

1533

12552

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

15.0

502

3452

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

15.0

406

2671

XQ800

NOMESCO Finland

Prick test

1.4

15.0

625

4483

M01AB55

ATC

diclofenac, combinations; oral

1.6

15.0

387

2519

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

15.0

507

3497

J01FA15

ATC

telithromycin; oral

1.4

14.9

739

5463

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.7

14.9

276

1656

G03DC02

ATC

norethisterone; oral

1.3

14.8

1013

7867

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

14.8

374

2422

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

14.8

708

5202

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.4

14.8

391

M43.1

ICD-10 Finland

Spondylolisthesis

1.6

14.7

302

1860

SPAT1238

SPAT

Brief therapy

2.0

14.7

153

767

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.7

14.7

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

14.7

445

3001

N06AX03

ATC

mianserin; oral

1.6

14.7

311

1932

G03DB01

ATC

dydrogesterone; oral

1.3

14.6

1388

11261

H01

ICPC

Ear pain/earache

1.3

14.5

951

7339

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

14.5

944

7278

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

14.5

279

1690

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

14.5

2002

16963

QBB10, ,

SPAT

2.4

14.5

100

425

SBB10

NOMESCO Finland

Dental impressions

1.5

14.5

490

3378

OAB72

NOMESCO Finland

Weight control and weight loss guidance

2.3

14.5

104

450

C10AC01

ATC

colestyramine; oral

1.8

14.5

214

1204

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.6

14.5

322

2024

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.7

14.4

290

1777

HAB40

NOMESCO Finland

Wedge excision of mammary gland

1.5

14.4

410

2728

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.7

14.4

291

1787

A10BJ06

ATC

semaglutide; parenteral

1.6

14.3

348

2233

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

14.3

352

2266

H92.0

ICD-10 Finland

Otalgia

1.5

14.3

525

3678

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

14.3

291

1789

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

14.3

1643

13637

R06AX13

ATC

loratadine; oral

1.3

14.2

1220

9769

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

14.2

199

1102

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.3

14.2

103

448

L11

ICPC

Wrist symptom/complaint

1.4

14.2

785

5907

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

14.1

308

1927

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.8

14.1

226

1303

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

2.9

14.0

216

HA1AE, ,

SPAT

1.6

14.0

343

2206

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

14.0

221

1268

J20

ICD-10 Finland

Acute bronchitis

1.4

13.9

787

5939

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

13.9

707

5246

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

13.8

723

5388

K04.0

ICD-10 Finland

Pulpitis

1.4

13.8

696

5157

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

2.1

13.8

128

615

T07

ICPC

Weight gain

2.0

13.8

154

792

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

13.8

1041

8195

HAA00

NOMESCO Finland

Incision of mammary gland

23.8

13.8

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.6

13.7

303

1901

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.0

13.7

145

731

S21

ICPC

Skin texture symptom/complaint

1.3

13.7

1016

7975

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.1

13.7

131

637

A98

ICPC

Health maint/preventive medicine

2.0

13.7

8080

79587

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

13.7

1580

13113

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.4

13.7

622

4531

R01AD59

ATC

mometasone, combinations; nasal

1.4

13.7

574

4123

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

3.4

13.7

142

N64

ICD-10 Finland

Other disorders of breast

4.2

13.6

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.0

13.6

135

666

M67.4

ICD-10 Finland

Ganglion

1.4

13.6

566

4060

G04BD07

ATC

tolterodine; oral

1.7

13.6

253

1521

L20

ICPC

Joint symptom/complaint NOS

1.6

13.5

309

1955

HA1BA

NOMESCO Finland

Extensive X-ray mammography

3.0

13.5

199

R09

ICPC

Sinus symptom/complaint

1.4

13.5

745

5599

N80.0

ICD-10 Finland

Endometriosis of uterus

1.7

13.5

227

1326

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

13.5

1148

9178

SGA01

NOMESCO Finland

Emergency treatment

1.3

13.5

1268

10267

N64.2

ICD-10 Finland

Atrophy of breast

34.1

13.5

K59.0

ICD-10 Finland

Constipation

1.6

13.4

339

2196

R03AC12

ATC

salmeterol; inhalant

1.7

13.4

253

1526

R4190

NOMESCO Finland

Nutritional therapy

1.6

13.4

275

1695

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

3.3

13.4

144

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

13.4

256

1550

R11

ICD-10 Finland

Nausea and vomiting

1.4

13.3

604

4396

C01CA24

ATC

epinephrine; parenteral

1.4

13.3

514

3638

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.3

13.3

1105

8811

G50.1

ICD-10 Finland

Atypical facial pain

1.9

13.3

153

796

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.7

13.2

223

1304

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

13.2

2573

22529

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

13.2

1864

15806

OAB91, ,

SPAT

1.4

13.2

642

4729

N06AA10

ATC

nortriptyline; systemic

1.9

13.2

171

925

A08

ICPC

Swelling

1.6

13.2

335

2175

J02AC02

ATC

itraconazole; systemic

1.3

13.1

1358

11128

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

3.5

13.0

122

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.7

13.0

258

1576

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

13.0

387

2599

SFA00

NOMESCO Finland

Small restoration

1.3

13.0

1052

8355

E03

ICD-10 Finland

Other hypothyroidism

1.4

13.0

520

3703

S83.2

ICD-10 Finland

Tear of meniscus, current

1.5

12.9

412

2807

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

12.9

2586

22689

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

12.9

249

1511

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.2

12.9

2228

19281

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

12.8

729

5504

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.7

12.8

222

1308

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

12.8

780

5950

G43

ICD-10 Finland

Migraine

1.4

12.8

530

3796

S01

ICPC

Pain/tenderness of skin

1.6

12.8

310

1990

SPAT1229

SPAT

Assessment of need for aid

1.5

12.8

380

2553

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

12.8

1272

10369

TQW40, ,

SPAT

1.4

12.7

670

4998

H81.3

ICD-10 Finland

Other peripheral vertigo

1.8

12.7

189

1066

WX400

NOMESCO Finland

Inhalation anesthesy

1.6

12.7

297

1890

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

12.7

181

1008

JG1JB

NOMESCO Finland

Defekography with X-ray

2.4

12.7

339

R52.0

ICD-10 Finland

Acute pain

1.7

12.7

240

1449

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

3.3

12.7

139

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

12.7

508

3619

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

12.6

452

3154

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

6.0

12.6

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

12.5

685

5140

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

12.5

153

812

CBB21

NOMESCO Finland

Correction of lax skin and resection of herniated fat in upper eyelid

2.7

12.4

231

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

12.4

1846

15722

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

12.4

454

3180

R50.9

ICD-10 Finland

Fever, unspecified

1.3

12.4

919

7212

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

1.4

12.4

710

5368

SPAT1262

SPAT

Handing over of treatment supplies

1.3

12.4

858

6670

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

12.4

304

1958

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

12.4

804

6194

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

12.4

271

1699

A08AA10

ATC

sibutramine; oral

3.5

12.3

117

WZC00, ,

SPAT

1.3

12.3

1077

8634

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

12.3

306

1978

A11

ICPC

Chest pain NOS

1.4

12.2

498

3556

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

12.2

499

3566

P29

ICPC

Psychological sympt/compl other

1.4

12.2

604

4461

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.4

12.2

689

5197

C10AX09

ATC

ezetimibe; oral

1.3

12.2

879

6871

OAB93, ,

SPAT

1.4

12.2

650

4861

NH3AA, ,

SPAT

1.4

12.2

512

3679

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.3

12.1

878

6866

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.6

12.1

268

1684

G57.6

ICD-10 Finland

Lesion of plantar nerve

1.8

12.1

178

1002

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.5

12.1

383

2609

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

12.0

315

2060

SPAT1269

SPAT

Other puncture and/or drainage

3.3

12.0

134

M76.6

ICD-10 Finland

Achilles tendinitis

1.5

12.0

351

2351

N64.3

ICD-10 Finland

Galactorrhoea not associated with childbirth

3.9

12.0

QBA00

NOMESCO Finland

Puncture of skin of trunk

3.9

12.0

UJD02

NOMESCO Finland

Gastroscopy

1.6

11.9

268

1691

M02AA15

ATC

diclofenac; topical

1.4

11.9

439

3080

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

3.4

11.9

125

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

4.5

11.9

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

11.8

676

5107

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.6

11.8

243

1499

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

11.8

315

2067

X26

ICPC

Fear of breast cancer female

2.6

11.8

255

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

11.8

466

3311

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.4

11.7

450

3179

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.4

11.7

334

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

2.7

11.7

222

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

11.6

202

1193

C09DA01

ATC

losartan and diuretics; oral

1.4

11.6

580

4290

A03FA02

ATC

cisapride; oral, rectal

1.4

11.6

431

3029

L84

ICPC

Back syndrome without radiat pain

1.5

11.5

326

2167

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

1.4

11.5

520

3781

R03BB04

ATC

tiotropium bromide; inhalant

1.4

11.5

464

3307

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

11.5

463

3299

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

11.5

245

1525

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

11.5

428

3006

NG1AA, ,

SPAT

1.3

11.5

694

5286

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.3

11.5

794

6167

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

11.5

420

2942

M50.3

ICD-10 Finland

Other cervical disc degeneration

1.8

11.5

168

945

R75

ICPC

Sinusitis acute/chronic

1.5

11.4

410

2860

R01AD11

ATC

triamcinolone; nasal

1.4

11.4

623

4672

R03DA04

ATC

theophylline; systemic, rectal

1.7

11.4

223

1358

N81.1

ICD-10 Finland

Cystocele

1.4

11.4

532

3891

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.5

11.4

366

2499

M02AA10

ATC

ketoprofen; topical

1.3

11.4

1050

8472

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.4

11.4

618

4634

A46

ICD-10 Finland

Erysipelas

1.3

11.3

678

5158

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

1.9

11.3

145

782

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.6

11.3

256

1619

S15

ICPC

Foreign body in skin

1.5

11.3

399

2777

3051, ,

Kela drug reimbursment

2.0

11.3

112

554

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

11.3

1247

10279

A97

ICPC

No disease

1.2

11.2

1346

11193

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.7

11.2

192

1130

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.8

11.1

152

837

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

1.5

11.1

363

2487

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

11.1

472

3397

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.4

11.1

449

3203

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

2.9

11.1

167

J05AB11

ATC

valaciclovir; oral

1.3

11.1

1096

8917

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

11.1

523

3834

U71

ICPC

Cystitis/urinary infection other

1.4

11.1

580

4325

J46

ICD-10 Finland

Status asthmaticus

1.7

11.1

210

1271

L29

ICPC

Musculoskeletal sympt/complt other

1.4

11.0

623

4701

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

1.7

11.0

183

1069

M54.1

ICD-10 Finland

Radiculopathy

1.6

11.0

279

1813

M01AH03

ATC

valdecoxib; oral

1.5

10.9

383

2661

N06AG02

ATC

moclobemide; oral

1.6

10.9

257

1640

R78

ICPC

Acute bronchitis/bronchiolitis

1.9

10.9

140

756

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

1.9

10.9

139

749

Z00.8

ICD-10 Finland

Other general examinations

1.4

10.9

507

3707

S02

ICPC

Pruritus

1.6

10.9

242

1524

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

10.8

448

3210

R03BC03

ATC

nedocromil; inhalant

1.4

10.8

475

3441

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

10.8

507

3715

A03CA02

ATC

clidinium and psycholeptics; oral

1.5

10.8

304

2022

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

10.7

368

2546

C08CA13

ATC

lercanidipine; oral

1.3

10.7

760

5923

M04AA01

ATC

allopurinol; systemic

1.5

10.7

373

2588

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

10.7

750

5836

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

10.7

1511

12777

N06BA12

ATC

lisdexamfetamine; oral

2.2

10.7

379

C09CA01

ATC

losartan; oral

1.2

10.7

1437

12089

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.5

10.7

343

2342

205

Kela drug reimbursment

Chronic hypertension

1.3

10.7

1033

8378

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

10.7

747

5812

M43.0

ICD-10 Finland

Spondylolysis

2.0

10.7

116

593

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.4

10.7

536

3970

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

3.3

10.6

119

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.6

10.6

221

1369

A10BK03

ATC

empagliflozin; oral

1.4

10.6

495

3620

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.6

10.6

225

1401

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

10.6

364

2520

SPAT1058

SPAT

PEF monitoring instruction

1.4

10.6

495

3623

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

10.6

525

3881

JN4BD

NOMESCO Finland

Extensive body CT

1.4

10.6

483

3522

X15

ICPC

Vaginal symptom/complaint other

1.5

10.5

377

2630

OAA11, ,

SPAT

0.6

10.5

155

2652

J01DC02

ATC

cefuroxime; systemic

1.5

10.5

382

2673

H29

ICPC

Ear symptom/complaint other

1.3

10.5

766

5995

C09DA06

ATC

candesartan and diuretics; oral

1.4

10.5

426

3044

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

4.6

10.5

J01AA07

ATC

tetracycline; systemic

1.3

10.5

1112

9120

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.3

10.4

809

6383

UDC00

NOMESCO Finland

Ear microscopy

1.4

10.4

427

3055

61199

ICD-8 Finland

Other diseases of breast, Other

+∞

10.4

PJW99

NOMESCO Finland

Other operation on lymphatic system

2.9

10.4

168

TNX10, ,

SPAT

2.2

10.4

365

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.3

10.4

744

5809

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

1.5

10.4

284

1877

L18

ICPC

Muscle pain

1.5

10.3

300

2008

EMB10

NOMESCO Finland

Tonsillectomy

1.4

10.3

424

3035

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

10.3

1811

15638

NA1BG, ,

SPAT

1.8

10.3

150

843

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.0

10.3

104

518

D06AX01

ATC

fusidic acid; topical

1.4

10.3

578

4356

M24.2

ICD-10 Finland

Disorder of ligament

2.0

10.3

101

498

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

1.8

10.3

140

771

K85

ICPC

Elevated blood pressure

1.3

10.3

975

7889

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

3.9

10.3

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

10.6

10.3

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.7

10.2

201

1228

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

10.2

662

5098

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.5

10.2

304

2047

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

10.2

254

1645

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

10.2

300

2015

K64.0

ICD-10 Finland

First degree haemorrhoids

1.7

10.1

170

996

L03.3

ICD-10 Finland

Cellulitis of trunk

2.4

10.1

269

M70.7

ICD-10 Finland

Other bursitis of hip

1.7

10.1

189

1140

A03

ICPC

Fever

1.2

10.1

1284

10735

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

10.1

110

564

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

10.0

683

5293

Y88.1

ICD-10 Finland

Sequelae of misadventures to patients during surgical and medical procedures

2.2

10.0

351

A04AA55

ATC

palonosetron, combinations; systemic

1.5

10.0

316

2151

S97

ICPC

Chronic ulcer skin

1.5

10.0

260

1698

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

10.0

776

6120

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.8

10.0

137

756

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

10.0

1257

10497

A03DA02

ATC

pitofenone and analgesics; systemic

2.0

10.0

106

538

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

10.0

244

1573

JF1BD

NOMESCO Finland

Very extensive small bowel CT

3.3

10.0

109

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

10.0

670

5185

N06AX22

ATC

agomelatine; oral

1.7

9.9

177

1054

B01AB10

ATC

tinzaparin; parenteral

1.3

9.9

724

5664

G02BA03

ATC

plastic IUD with progestogen

1.2

9.9

1364

11495

M35.7

ICD-10 Finland

Hypermobility syndrome

1.8

9.9

138

766

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.7

9.9

160

928

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.6

9.9

211

1317

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

9.9

539

4046

A01AB09

ATC

miconazole; local oral

1.4

9.8

540

4057

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

1.9

9.8

116

611

QDJ00

NOMESCO Finland

Liposuction in lower extremity

4.4

9.8

R4120

NOMESCO Finland

Occupational therapy

1.4

9.8

407

2921

A29

ICPC

General symptom/complaint other

1.3

9.7

807

6422

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

2.5

9.7

238

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.7

9.7

191

1168

R15

ICD-10 Finland

Faecal incontinence

1.6

9.7

195

1199

B29

ICPC

Lymph/immune mech sympt/complt other

3.4

9.7

101

M65.3

ICD-10 Finland

Trigger finger

1.5

9.7

345

2406

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.6

9.7

227

1449

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.0

9.7

104

530

SPAT1139

SPAT

Nutrition survey

1.7

9.7

187

1138

D07AA02

ATC

hydrocortisone; topical

1.3

9.7

946

7679

L14

ICPC

Leg/thigh symptom/complaint

1.4

9.7

523

3919

N03AX11

ATC

topiramate; oral

1.6

9.7

212

1332

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

9.7

1469

12504

1410

FHL

Laparoscopy

1.5

9.7

251

1641

ULC02

NOMESCO Finland

Hysteroscopy

1.4

9.6

462

3396

D93

ICPC

Irritable bowel syndrome

1.9

9.6

116

615

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.0

9.6

103

525

Z31.5

ICD-10 Finland

Genetic counselling

1.4

9.6

446

3262

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

9.6

294

1991

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.5

9.6

283

1902

DHB50

NOMESCO Finland

Turbinoplasty

1.7

9.6

156

907

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

9.6

287

1935

T78.4

ICD-10 Finland

Allergy, unspecified

1.4

9.6

365

2579

D05.0

ICD-10 Finland

Lobular carcinoma in situ

4.3

9.6

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

9.5

1377

11660

D07AC13

ATC

mometasone; topical

1.2

9.5

2004

17568

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.3

9.5

716

5626

F60.5

ICD-10 Finland

Anankastic personality disorder

2.0

9.5

479

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.5

9.5

293

1987

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.6

9.5

199

1237

K86

ICPC

Hypertension uncomplicated

1.3

9.5

702

5503

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.6

9.5

187

1145

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

9.5

215

1363

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

9.5

1788

15528

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.3

9.4

635

4915

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

9.4

263

1747

X23

ICPC

Fear sexually transm dis female

1.4

9.4

437

3196

D09

ICPC

Nausea

1.4

9.4

348

2445

R49.01

ICD-10 Finland

Functional dysphonia

1.6

9.4

226

1452

6110A

ICD-9 Finland

Other disorders of breast, Inflammatory disease of breast

+∞

9.4

N02AJ13

ATC

tramadol and paracetamol; systemic

1.7

9.4

152

883

R51.81

ICD-10 Finland

Facial pain NOS

1.6

9.3

184

1126

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.6

9.3

199

1242

A05

ICPC

Feeling ill

1.4

9.3

429

3132

C03DA01

ATC

spironolactone; oral

1.3

9.3

550

4176

G04CA02

ATC

tamsulosin; oral

1.7

9.3

152

884

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.5

9.3

333

2324

R52.1

ICD-10 Finland

Chronic intractable pain

2.3

9.3

311

S06

ICPC

Rash localized

1.4

9.3

334

2333

R06AX26

ATC

fexofenadine; oral

1.3

9.3

550

4177

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.0

9.3

100

510

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

2.0

9.3

103

531

D06BB03

ATC

aciclovir; topical

1.4

9.3

343

2409

A02BA04

ATC

nizatidine; systemic

1.4

9.3

382

2736

R60.9

ICD-10 Finland

Oedema, unspecified

1.4

9.3

336

2351

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

2.3

9.3

274

H02

ICPC

Hearing complaint

1.3

9.3

733

5796

M09AX01

ATC

hyaluronic acid; parenteral

1.6

9.3

212

1346

SPAT1097

SPAT

Recording of ECG

1.3

9.3

724

5716

F43.01

ICD-10 Finland

Acute stress reaction moderate

1.7

9.3

154

901

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.2

9.2

338

G04BD11

ATC

fesoterodine; oral

1.7

9.2

145

835

S02.51

ICD-10 Finland

Fracture of tooth, open

1.3

9.2

670

5241

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.4

9.2

383

2750

B01AB04

ATC

dalteparin; parenteral

1.5

9.2

288

1960

-54

ICPC

Repair/fix-suture/cast/prosth device

1.8

9.2

126

697

D25

ICPC

Abdominal distension

1.7

9.2

151

881

D06BX01

ATC

metronidazole; topical

1.3

9.2

844

6802

HAC25

NOMESCO Finland

Radical mastectomy

3.5

9.2

G47.8

ICD-10 Finland

Other sleep disorders

1.7

9.2

162

964

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.5

9.2

314

2175

S01GX08

ATC

ketotifen; ophthalmic

1.4

9.1

364

2593

M01AX01

ATC

nabumetone; oral

1.5

9.1

246

1622

NA3BG, ,

SPAT

1.5

9.1

307

2119

QAJ30

NOMESCO Finland

Other facelift

3.9

9.1

HA1RA, ,

SPAT

1.4

9.1

412

3000

S76

ICPC

Skin infection other

1.5

9.1

292

1996

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.2

9.1

1547

13302

OAB50, ,

SPAT

1.4

9.1

436

3208

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

9.1

471

3509

R29

ICPC

Respiratory symptom/complaint other

1.4

9.1

456

3380

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

9.0

483

3613

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

9.0

216

1386

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

4.0

9.0

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

3.3

9.0

101

EMAK, ,

NOMESCO Finland

1.6

9.0

228

1483

Z73.0

ICD-10 Finland

Burn-out

1.4

9.0

358

2550

A04AA01

ATC

ondansetron; systemic, rectal

1.3

8.9

551

4211

U04

ICPC

Incontinence urine

1.5

8.9

310

2152

WX720

NOMESCO Finland

Own respiration

1.5

8.9

284

1938

J30.3

ICD-10 Finland

Other allergic rhinitis

1.5

8.9

267

1800

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

1.8

8.9

124

689

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

1.7

8.9

141

814

J01

ICD-10 Finland

Acute sinusitis

1.4

8.9

475

3553

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.5

8.9

279

1899

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4899

34636

2.03

202.84

2.6

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

3450

23402

1.82

143.16

2.1

2.2

—

(40768804) Tissue Pathology biopsy report

4381

32948

1.71

118.40

2.2

2.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4707

37720

1.58

85.75

6.1

9.46

9.87

umol/l

2.70

4431

35860

(3013826) Glucose [Moles/volume] in Serum or Plasma

4937

40171

1.58

82.75

4.3

4.4

6.26

6.43

mmol/l

8.95

4676

37646

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1123

6217

1.93

82.14

3.0

2.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6443

55990

1.70

81.70

8.3

7.9

76.59

76.67

u/l

0.05

6165

53349

(40768793) Breast Pathology biopsy report

547

2361

2.41

75.68

1.4

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

1351

8168

1.78

73.99

1.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2461

17519

1.58

71.43

2.0

2.1

—

(3002256) Pathology report gross observation

1601

10288

1.69

70.09

1.4

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7851

73499

2.59

69.28

16.3

14.3

3.92

mmol/l

0.18

7726

71973

(3019550) Sodium [Moles/volume] in Serum or Plasma

7839

73351

2.55

68.96

16.1

14.2

139.86

139.77

mmol/l

2.82

7730

71975

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7090

64063

1.79

68.70

5.8

5.0

14.43

14.51

pmol/l

2.48

6683

60271

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

6424

56754

1.61

65.48

4.8

4.4

11.00

11.22

mm/h

0.76

6108

53808

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7370

67866

1.85

60.31

6.3

5.5

37.95

38.04

mmol/mol

0.50

7002

64398

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3022

23196

1.48

58.82

2.6

54.43

60.47

u/l

3.31

2798

21537

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4509

37475

1.45

57.31

2.9

2.5

76.71

2430.05

nmol/l

0.50

4212

34857

(3015377) Calcium [Moles/volume] in Serum or Plasma

3313

26023

1.46

56.62

3.3

3.4

2.36

mmol/l

0.09

3053

23955

(3044889) 12 lead EKG panel

5745

50120

1.49

56.05

3.9

3.4

0.50

0.34

—

(3032080) INR in Blood by Coagulation assay

3552

28338

1.45

55.54

8.3

9.4

1.10

1.13

inr

2.33

2951

23114

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7656

71705

2.02

54.70

7.0

6.0

1.73

1.81

mu/l

8.56

7277

68064

(3024561) Albumin [Mass/volume] in Serum or Plasma

3860

31387

1.43

53.81

4.3

4.7

36.82

36.53

g/l

3.32

3613

29583

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4866

41335

1.44

52.89

3.6

3.2

82.53

84.85

ug/l

0.41

4587

39148

(3021960) Folate [Moles/volume] in Serum or Plasma

2512

18966

1.47

51.44

1.8

1.6

21.60

20.99

nmol/l

1.30

2153

16386

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3756

30652

1.42

49.88

2.3

2.0

100.14

100.13

pmol/l

0.00

1952

15540

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7512

70266

1.82

48.82

5.5

4.7

5.74

5.72

mmol/l

1.31

7064

66000

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7748

73307

2.03

47.01

15.2

13.3

18.01

20.02

mg/l

8.22

6716

59213

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

7509

70385

1.79

46.28

14.2

12.4

86.69

85.67

ml/min/173m2

5.29

7052

64645

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1973

14465

1.48

45.94

1.8

1.6

36000444.47

39350536.58

pmol/l

0.09

1675

12371

(3042936) Bacteria identified in Isolate by Culture

1354

9173

1.57

45.68

2.1

1.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5004

43304

1.40

45.08

8.6

9.7

3.96

3.91

e9/l

0.89

4428

37880

(40768797) Stomach Pathology biopsy report

1554

10896

1.53

44.78

1.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4182

35168

1.39

44.48

6.1

6.4

1.23

1.22

mmol/l

3.80

3576

30483

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2241

16952

1.44

43.97

1.4

1.3

6.91

10.56

u/ml

2.82

881

7156

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3760

31221

1.38

42.42

5.5

5.8

1.22

mmol/l

2.01

3495

29089

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2385

18398

1.42

41.50

1.4

36.14

29.26

iu/ml

0.31

755

5809

(3031040) Bacteria [#/volume] in Urine by Automated count

5523

48907

1.40

41.36

5.0

4.4

898.42

2559.16

e6/l

2.28

545

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8027

77371

2.75

40.96

19.0

16.4

67.16

67.67

umol/l

1.68

7972

76594

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2287

17679

1.41

38.77

1.8

1.7

0.77

0.94

mg/l

4.74

1785

13615

(3033658) Prothrombin time (PT) actual/Normal

2320

17992

1.40

38.56

3.5

3.7

99.42

97.09

5.38

2245

17499

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2995

24275

1.37

37.90

3.2

3.1

22.17

56.73

ng/l

0.83

1647

13489

(3037467) Urinalysis macro (dipstick) panel - Urine

5665

50841

1.37

35.83

4.8

4.5

2.72

2.33

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2359

18597

1.38

34.77

2.5

2.3

2.61

2.71

mg/l

1.90

2083

16186

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5861

53095

1.36

33.44

3.6

3.1

40.82

38.36

u/l

1.45

5526

50575

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2644

21327

1.35

33.37

1.4

1.3

1.09

1.58

u/ml

2.23

825

6172

(3009508) Creatinine [Moles/volume] in Urine

2778

22600

1.35

33.06

2.9

3.2

7.35

6.95

mmol/l

4.53

2301

19384

(3013115) Eosinophils [#/volume] in Blood

4583

40192

1.32

31.72

5.9

6.6

0.19

0.18

e9/l

1.20

4064

35662

(3018418) pH of Serum or Plasma

2654

21572

1.34

31.35

3.8

3.9

7.40

0.72

1890

15195

(3021601) Nitrite [Presence] in Urine by Test strip

4588

40279

1.32

31.31

4.2

3.8

0.00

estimate

0.39

1049

8176

(3009261) Glucose [Presence] in Urine by Test strip

4666

41062

1.32

31.28

4.2

3.8

0.01

0.26

estimate

0.84

1045

8143

(3001604) Monocytes [#/volume] in Blood

4434

38823

1.31

30.46

5.8

6.4

0.53

0.54

e9/l

0.83

3882

33865

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7702

73752

1.73

30.33

6.1

5.3

2.89

2.88

mmol/l

0.61

7297

69924

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3138

26221

1.32

30.28

3.2

30.91

30.71

u/l

0.06

2950

24901

(3035350) Ketones [Presence] in Urine by Test strip

4621

40726

1.31

30.06

4.2

3.8

0.01

4.24

estimate

5.90

1068

8388

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7617

72780

1.65

29.54

5.4

4.7

1.51

1.58

mmol/l

54.86

7206

68968

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7976

77275

2.16

29.52

13.1

11.4

25.89

24.17

u/l

7.59

7815

75484

(3006315) Basophils [#/volume] in Blood

4431

38889

1.30

29.43

5.8

6.4

0.04

e9/l

0.28

3885

33888

(3019309) Folate [Moles/volume] in Red Blood Cells

1361

10010

1.43

29.39

1.9

1.7

1260.26

1183.20

nmol/l

2.28

1053

7744

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2552

20776

1.33

29.35

2.1

140.34

158.17

u/l

0.61

2425

19688

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1111

7876

1.47

29.13

2.0

2.2

360.38

378.00

nmol/l

2.38

1040

7335

(3019198) Lymphocytes [#/volume] in Blood

4508

39748

1.30

28.47

5.8

6.4

2.04

1.94

e9/l

3.15

4021

35502

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1488

11175

1.41

28.45

3.0

3.3

0.83

0.82

mmol/l

1.83

1389

10555

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1821

14163

1.37

28.12

2.5

2.7

2.44

mmol/l

0.29

1647

12788

(3012516) Albumin [Mass/volume] in Urine

2487

20299

1.32

27.72

3.1

3.3

26.50

37.35

mg/l

2.45

1356

11554

(3029937) Albumin [Presence] in Urine by Test strip

2641

21745

1.32

27.64

4.4

4.0

0.01

0.00

estimate

0.28

1037

7889

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5889

53957

1.32

27.30

3.6

3.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7630

73099

1.63

27.22

5.5

4.8

4.86

4.89

mmol/l

2.38

7249

69557

(3020682) Albumin/Creatinine [Ratio] in Urine

2502

20538

1.31

26.50

3.6

3.9

5.31

7.44

mg/mmol

1.48

1346

11633

(3048689) Calprotectin [Mass/mass] in Stool

1572

12042

1.38

26.47

2.2

2.4

96.72

108.75

ug/g

1.17

1233

9525

(3021589) Normoblasts [#/volume] in Blood

3869

33635

1.28

26.40

11.0

10.3

0.00

e9/l

0.01

3223

27408

(3026008) Bacteria identified in Urine by Culture

2777

23134

1.30

26.34

3.2

2.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2256

18311

1.32

25.75

2.1

2.3

317.56

305.19

umol/l

9.64

2015

16441

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7273

69086

1.47

25.61

4.5

4.0

1.35

1.23

mmol/l

39.18

6816

64998

(3005322) IgE [Units/volume] in Serum or Plasma

909

6360

1.48

25.24

1.4

1.3

298.15

175.72

u/ml

0.54

853

5941

(3015736) pH of Urine

3722

32326

1.28

25.10

3.6

3.4

6.20

6.22

0.78

2151

18415

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3563

30870

1.27

24.17

4.1

3.6

0.15

0.43

estimate

0.82

864

6667

(3030467) Casts [#/volume] in Urine by Automated count

2280

18672

1.31

24.05

3.0

2.9

0.38

0.37

e6/l

0.07

1673

13263

(3006504) Eosinophils/Leukocytes in Blood

4019

35379

1.27

23.70

5.8

6.5

2.84

2.81

0.39

3784

33322

(3019069) Monocytes/Leukocytes in Blood

4024

35436

1.27

23.63

5.9

6.6

8.18

8.40

6.31

3796

33428

(1002224) Polysomnography panel

634

4170

1.56

23.48

1.1

—

(3022145) Colonoscopy Study observation

1180

8804

1.40

22.97

1.3

1.4

—

(3022096) Basophils/Leukocytes in Blood

4009

35363

1.26

22.92

5.9

6.6

0.70

0.71

0.80

3770

33246

(3000850) Epithelial cells [#/volume] in Urine

1842

14732

1.32

22.87

2.6

8.82

7.84

e6/l

1.41

1675

13339

(3002030) Lymphocytes/Leukocytes in Blood

4119

36492

1.26

22.51

5.8

6.4

29.86

29.42

2.15

3918

34755

(3002582) Erythrocytes [#/volume] in Urine

2576

21624

1.28

22.01

3.1

40.55

61.26

e6/l

0.76

1964

16098

(3023368) Bacteria identified in Blood by Culture

1956

15850

1.31

21.94

3.8

4.0

—

(40761536) Microorganisms panel - Urine sediment

856

6087

1.45

21.72

4.2

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

2260

18696

1.29

21.60

4.3

4.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3716

32639

1.25

21.49

2.0

1.9

1.45

1.33

mmol/l

12.67

3119

27957

(1617658) Protocol used for examination of sentinel lymph nodes

181

834

2.20

21.47

1.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2675

22653

1.27

21.04

3.5

3.1

0.33

0.18

estimate

0.22

894

6683

(42870588) Differential panel, method unspecified - Blood

2906

24880

1.26

20.76

5.5

6.5

—

4.84

—

(3018010) Neutrophils/Leukocytes in Blood

4037

35883

1.25

20.67

5.6

6.3

56.08

56.36

0.90

3875

34413

(3018095) Leukocytes [#/volume] in Urine

3045

26235

1.26

20.53

3.7

103.17

89.78

e6/l

0.30

2134

17504

(3007164) IgA [Mass/volume] in Serum or Plasma

2177

18028

1.28

20.41

1.5

2.22

2.19

g/l

0.36

1367

11504

(3013139) Helicobacter pylori Ag [Presence] in Stool

868

6260

1.43

20.36

1.3

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1027

7669

1.39

19.69

1.4

1.3

29.17

31.43

iu/l

1.36

897

6686

(36304419) Bacteria [Presence] in Urine

2167

18041

1.27

19.24

3.0

2.9

2561.26

3.87

estimate

—

(3025941) Bacteria identified in Stool by Culture

664

4603

1.48

19.13

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

882

6468

1.41

18.77

2.1

2.3

0.23

0.22

g/l

4.92

823

6103

(3007461) Platelets [#/volume] in Blood

8133

80047

2.88

18.72

24.4

20.7

272.98

268.13

e9/l

11.21

8048

78779

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

6694

63388

1.30

18.51

18.2

16.2

13.47

13.48

0.35

6633

62595

(3035941) MCH [Entitic mass]

8133

80071

2.84

18.26

24.2

20.6

30.08

30.12

1.73

8092

79476

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

8133

80079

2.83

18.10

24.7

21.0

40.25

40.41

0.46

8092

79450

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1984

16442

1.27

18.09

2.5

2.7

600.22

781.31

ng/l

1.98

1634

13804

(3026361) Erythrocytes [#/volume] in Blood

8133

80082

2.83

18.04

24.3

20.7

4.47

4.44

e12/l

9.56

8032

78622

(3010813) Leukocytes [#/volume] in Blood

8133

80087

2.82

17.95

24.4

20.7

6.66

6.53

e9/l

7.48

8028

78610

(3024731) MCV [Entitic mean volume] in Red Blood Cells

8132

80076

2.79

17.87

24.2

20.6

90.62

90.77

2.54

8091

79478

(3000963) Hemoglobin [Mass/volume] in Blood

8133

80097

2.80

17.75

24.5

20.8

133.74

133.03

g/l

7.86

8093

79507

(3037522) Nuclear Ab [Titer] in Serum

1628

13206

1.29

17.54

1.4

489.43

570.10

titre

1.09

348

2977

(3006653) Thiamine [Moles/volume] in Blood

100

388

2.60

17.50

1.5

1.4

131.56

130.56

nmol/l

0.09

100

388

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1080

8295

1.35

17.19

3.8

5.2

1.04

mmol/l

0.03

998

7666

(4035726) Immunohistochemistry procedure

851

6330

1.38

16.57

1.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

752

5513

1.40

15.94

3.3

3.4

1.23

mmol/l

0.11

633

4767

(3003694) ABO and Rh group [Type] in Blood

2558

22073

1.23

15.89

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1283

10231

1.30

15.56

2.3

2.0

—

(3026782) Osmolality of Urine

1501

12230

1.28

15.37

2.8

2.7

505.35

500.95

mosm/kgh2o

0.32

1309

10698

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

282

1695

1.69

15.08

1.9

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1446

11755

1.28

15.05

2.2

2.4

14.12

13.77

umol/l

0.95

1337

10986

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

293

1781

1.67

15.02

4.3

3.7

46.84

33.66

u/ml

0.39

287

1714

(1761868) Lipid panel - Serum or Plasma

3663

32889

1.21

14.94

3.2

2.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1332

10789

1.28

14.20

2.2

2.4

2.51

2.43

g/l

5.82

1220

9968

(3002179) Metamyelocytes/Leukocytes in Blood

814

6193

1.35

13.65

3.8

4.4

0.75

0.71

0.17

218

1628

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

501

3535

1.44

13.14

1.5

1.6

17.48

13.90

u/ml

0.32

106

885

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

770

5858

1.35

12.90

1.5

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1204

9760

1.27

12.63

2.2

2.5

22.91

22.76

0.15

1094

9071

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1376

11341

1.26

12.55

2.4

2.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1085

8705

1.28

12.35

2.6

2.5

5.99

6.85

umol/l

0.89

888

7438

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1447

12036

1.25

12.13

3.2

3.3

67.93

295.96

ng/l

10.05

892

7784

(3017181) Myelocytes/Leukocytes in Blood

833

6478

1.32

11.98

3.9

4.5

1.22

0.93

1.43

217

1698

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1215

9932

1.26

11.84

1.8

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

471

3362

1.43

11.62

1.7

3.69

4.04

mg/l

0.43

403

2498

(3045414) Leukocytes [Presence] in Urine

932

7407

1.29

11.39

2.1

0.02

estimate

0.05

187

1546

(3025159) Blasts/Leukocytes in Blood

816

6372

1.31

11.38

4.1

4.8

0.07

0.29

1.39

182

1397

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1105

8991

1.26

11.16

1.6

1.37

1.35

0.86

974

8018

(3021440) Promyelocytes/Leukocytes in Blood

795

6239

1.30

10.67

4.0

4.6

0.25

0.11

1.77

178

1461

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

826

6522

1.30

10.59

2.0

1.8

—

(3017732) Neutrophils [#/volume] in Blood

1236

10249

1.24

10.53

2.6

3.1

4.20

4.19

e9/l

0.02

1098

9064

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

475

2.08

10.44

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

944

7599

1.27

10.39

5.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

770

6063

1.30

10.07

2.7

2.9

10.05

10.42

g/l

2.28

702

5646

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

888

7128

1.28

9.99

2.3

2.4

34.98

37.21

u/l

0.36

759

5956

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

331

2282

1.47

9.86

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

644

4963

1.32

9.86

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

625

4820

1.32

9.52

1.5

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

828

6632

1.28

9.47

3.5

4.51

4.49

pmol/l

0.13

747

6005

(36660697) Celiac disease serology panel - Serum

914

7415

1.26

9.40

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

886

7173

1.26

9.27

1.7

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

456

3369

1.37

9.23

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

137

783

1.76

8.96

2.0

25.47

26.17

mg/l

0.07

296

(3000570) Elastase.pancreatic [Mass/mass] in Stool

328

2303

1.44

8.92

1.4

299.53

291.77

ug/g

0.26

171

1227

(3019150) Specific gravity of Urine by Refractometry

2022

17826

1.18

8.89

4.2

3.9

1.02

1.19

kg/l

0.80

1348

11590

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

960

7894

1.24

8.75

2.2

1.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

840

6815

1.26

8.62

1.7

1.8

—

(3019225) pH of Specimen

791

6375

1.27

8.58

3.5

3.8

7.34

7.36

0.67

565

4477

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

713

5674

1.28

8.58

2.8

3.4

71.26

78.16

ng/l

1.90

618

4958

(3000494) Fungus identified in Specimen by Culture

1101

9221

1.22

8.44

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

370

2682

1.40

8.43

1.5

1.9

—

(44806420) Estimation of glomerular filtration rate

193

1230

1.58

8.36

2.5

2.4

—

(40768443) Skin Pathology biopsy report

468

3529

1.35

8.34

1.2

—

(3008898) HLA-B27 [Presence]

484

3669

1.34

8.32

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

346

2485

1.41

8.32

1.9

2.3

—

(3009343) pH of Capillary blood

463

3497

1.34

8.16

2.4

3.2

7.42

0.55

372

2892

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

473

3614

1.33

7.72

2.4

3.3

5.13

5.17

kpa

0.49

445

3474

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

301

2147

1.42

7.56

1.1

1.68

1.90

u/ml

0.16

136

1083

(3003888) Timothy IgE Ab [Units/volume] in Serum

263

1843

1.44

7.30

1.1

3.77

4.29

u/ml

0.22

127

910

(3022806) Fractional oxyhemoglobin in Capillary blood

112

648

1.74

7.11

1.7

91.28

90.39

1.40

112

639

(3045424) Erythrocytes [Presence] in Urine

476

3685

1.31

7.10

2.1

0.04

0.06

estimate

0.10

160

1280

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

287

2056

1.41

7.06

1.2

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

448

1.88

6.97

1.6

1.9

105.95

100.94

0.67

407

(3016879) Cocaine [Presence] in Urine

418

3188

1.33

6.94

1.5

1.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

122

728

1.69

6.94

1.3

1.2

2.39

1.47

u/ml

0.39

400

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

303

2199

1.39

6.92

1.4

28.68

32.41

u/l

1.14

252

1785

(3012501) Base excess in Blood by calculation

178

1166

1.54

6.91

2.9

3.2

2.44

2.53

mmol/l

0.18

122

782

(3028026) IgM [Mass/volume] in Serum or Plasma

596

4767

1.27

6.91

1.6

1.9

1.17

1.34

g/l

3.10

556

4431

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

928

7799

1.21

6.83

1.2

120.10

150.59

u/ml

1.75

377

3188

(3017143) Hepatitis C virus Ab [Presence] in Serum

1142

9817

1.19

6.58

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

250

1771

1.42

6.58

1.1

1.12

0.91

u/ml

0.31

715

(3003329) Lymphocytes/Leukocytes in Synovial fluid

567

1.76

6.55

1.8

1.6

38.91

38.61

0.03

311

(3015171) Extractable nuclear Ab [Units/volume] in Serum

502

3965

1.28

6.45

1.3

0.36

1.17

u/ml

2.84

332

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

401

3076

1.32

6.42

1.3

30.51

38.43

u/ml

0.26

194

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

295

2.04

6.32

1.1

1.0

101.88

93.40

2.06

113

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

982

8364

1.20

6.27

4.9

4.5

32.35

32.89

0.85

690

5851

(44816559) Phosphatidylethanol [Mass/volume] in Blood

383

2930

1.32

6.26

1.6

0.27

0.28

mg/l

0.19

155

1175

(3010726) Horse dander IgE Ab [Units/volume] in Serum

245

1746

1.42

6.25

1.1

1.63

1.35

u/ml

0.21

116

825

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

436

1.84

6.25

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

2503

22904

1.13

6.16

3.0

2.8

0.04

0.05

398

(3028707) Methadone [Presence] in Urine by Screen method

211

1469

1.45

6.13

1.7

2.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

198

1366

1.46

6.04

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

441

3460

1.29

5.99

1.4

1.8

—

(3020961) Endomysium IgA Ab [Titer] in Serum

577

4682

1.25

5.94

1.1

19.29

198.89

titre

—

136

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

156

1029

1.53

5.93

1.4

1.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

218

1544

1.42

5.79

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

387

3000

1.30

5.77

2.2

3.1

1.76

1.75

mmol/l

0.01

285

2250

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

281

2079

1.36

5.77

1.3

1.4

0.44

0.42

nmol/l

0.13

208

1567

(3011397) Hemoglobin [Presence] in Urine by Test strip

2023

18357

1.14

5.59

3.9

3.7

0.10

0.20

—

155

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1318

11615

1.16

5.55

2.8

2.6

1.11

1.52

e6/l

0.79

678

5892

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

291

1.97

5.47

1.1

107.03

94.76

2.22

116

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

357

2759

1.31

5.47

2.0

0.24

0.23

g/l

1.01

336

2633

(3000764) Benzodiazepines [Presence] in Urine

438

3479

1.27

5.43

1.5

1.8

—

(3027008) Opiates [Presence] in Urine

439

3493

1.27

5.37

1.5

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

222

1602

1.40

5.34

1.1

5.20

3.80

u/ml

0.25

100

746

(40758558) Short blood count panel - Blood

2495

22991

1.12

5.31

5.8

6.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

302

1.93

5.27

1.1

127.92

116.80

1.55

269

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

555

4549

1.24

5.24

1.1

1.34

2.10

u/ml

0.62

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1189

10442

1.16

5.23

2.8

2.7

5.21

4.63

e6/l

0.60

539

4712

(3028300) Cannabinoids [Presence] in Urine

439

3506

1.27

5.21

1.5

1.8

—

(4024509) Urine culture

435

3481

1.26

5.09

1.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

362

2839

1.29

4.99

1.9

1.26

1.20

g/l

3.95

342

2718

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

419

5208

0.79

4.98

1.4

1.6

986.84

1001.72

mu/l

0.12

315

4339

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

322

2491

1.30

4.93

1.2

3.33

4.13

1.16

412

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

100

625

1.61

4.88

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

133

887

1.51

4.88

1.6

1.5

1.62

1.46

nmol/l

0.29

115

748

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

618

1.61

4.86

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

492

4016

1.24

4.85

2.1

2.7

72.83

129.12

ng/l

12.82

436

3674

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1400

0.62

4.84

1.3

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

162

1128

1.44

4.80

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

287

2196

1.32

4.77

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

305

2355

1.31

4.75

1.3

2.91

2.89

u/ml

0.00

161

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

187

1340

1.40

4.73

1.1

0.19

0.27

u/ml

0.25

385

(3025018) Bordetella pertussis Ab [Titer] in Serum

115

751

1.54

4.67

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1045

9167

1.16

4.66

1.9

2.1

28.90

29.09

0.63

1011

8896

(3030981) Hyaline casts [#/volume] in Urine by Automated count

620

5204

1.21

4.66

2.2

2.3

0.41

0.35

e6/l

0.23

588

4884

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

137

929

1.48

4.66

1.3

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

288

2213

1.31

4.65

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

207

1514

1.38

4.64

1.1

4.56

u/ml

0.00

641

(3050129) First trimester maternal screen panel - Serum or Plasma

263

3433

0.76

4.64

1.5

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

360

2851

1.27

4.62

1.3

1.4

7.20

8.20

u/ml

0.14

459

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

139

947

1.48

4.62

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

288

2216

1.31

4.61

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

360

2852

1.27

4.61

1.3

6.70

5.44

u/ml

0.14

298

(3021447) Carbon dioxide [Partial pressure] in Venous blood

632

5322

1.20

4.59

3.0

3.7

5.79

5.82

kpa

0.25

610

5192

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

932

1.48

4.59

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

566

1.61

4.56

1.4

17.52

24.66

umol/l

2.40

519

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

566

4731

1.21

4.45

2.2

2.1

3463.09

5302.62

u/l

1.12

194

1858

(4094501) Cardiovascular stress test using bicycle ergometer

253

1922

1.33

4.45

1.0

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

151

1057

1.44

4.38

1.4

325.49

377.21

pmol/l

0.69

124

930

(3012544) pH of Venous blood

636

5386

1.20

4.36

3.0

3.7

7.38

0.32

312

2995

(3024522) Salmonella sp identified in Specimen by Organism specific culture

135

927

1.46

4.34

1.4

—

(40758358) Immune stain study

4.25

4.31

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

242

1837

1.33

4.29

3.3

2.8

2.32

1.92

index

0.31

127

918

(3034891) Synovial lining cells/cells in Synovial fluid

332

1.78

4.28

1.8

1.5

3.00

3.95

0.31

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

111

735

1.52

4.27

1.4

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

422

1.69

4.26

1.7

2.08

1.94

umol/l

0.78

382

(44813793) Dust mix specific IgE antibody measurement

104

681

1.53

4.21

1.0

1.1

—

(3002032) Base excess in Venous blood by calculation

611

5180

1.19

4.15

2.9

3.7

1.86

1.91

mmol/l

0.13

543

4595

(4146454) Self-monitoring of blood glucose

557

1.59

4.14

2.8

2.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

527

4410

1.21

4.12

2.9

3.1

4.41

4.58

kpa

1.40

512

4296

(3021788) Differential panel - Synovial fluid

177

1291

1.38

4.09

1.6

—

1.00

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

249

1913

1.31

4.08

2.2

3.3

25.00

24.97

mmol/l

0.06

226

1780

(3025468) Yersinia sp identified in Specimen by Organism specific culture

128

882

1.46

4.07

1.3

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

310

2452

1.27

4.06

1.2

1.3

126.41

149.96

titre

0.24

242

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

167

1209

1.39

4.04

1.7

1.6

—

(3011985) Renin [Units/volume] in Plasma

161

1160

1.40

4.01

1.7

1.5

50.29

58.26

mu/l

0.28

143

1050

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

114

771

1.49

3.99

1.4

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

128

887

1.45

3.96

1.3

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

346

2785

1.25

3.93

2.9

3.0

0.61

0.62

0.30

346

2771

(3005988) Vibrio sp identified in Specimen by Organism specific culture

128

889

1.45

3.92

1.3

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

429

3538

1.22

3.90

1.7

308.42

312.58

mu/l

0.09

387

3153

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

159

1150

1.39

3.88

1.5

1.7

407.11

385.02

mu/l

0.17

132

905

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

571

4845

1.19

3.86

1.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

244

1886

1.30

3.85

2.4

2.7

25.06

24.93

mmol/l

0.25

239

1860

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

571

4853

1.19

3.79

1.6

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

218

1664

1.32

3.77

2.0

5.46

5.27

mmol/24h

0.32

197

1505

(3023420) DNA double strand Ab [Units/volume] in Serum

487

4083

1.20

3.76

2.0

11.47

7.31

iu/ml

0.77

114

990

(3004716) Salmonella sp identified in Stool by Organism specific culture

557

4733

1.19

3.71

1.4

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

364

1.68

3.66

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

780

6822

1.16

3.64

3.7

4.0

21.76

23.34

ug/l

0.06

586

5241

(3049717) Cytology report of Urine Cyto stain

190

1434

1.33

3.58

2.1

2.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

208

1593

1.31

3.54

1.4

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

160

1181

1.36

3.49

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

129

922

1.41

3.43

1.2

59.87

48.51

u/ml

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

139

1896

0.73

3.41

1.4

1.5

55.05

59.23

ug/l

0.49

139

1896

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

448

3764

1.20

3.41

1.4

216.91

230.90

miu/ml

0.35

210

1889

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

350

1.66

3.37

1.3

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

381

1.63

3.36

1.2

160.41

140.79

mmol/24h

1.02

381

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

667

5803

1.16

3.36

1.3

37.24

48.20

au/ml

0.70

379

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

714

6244

1.16

3.36

2.4

19.83

22.15

au/ml

0.44

775

(3021879) Hepatitis B virus core Ab [Presence] in Serum

745

6540

1.15

3.32

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

172

1296

1.33

3.30

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

177

2314

0.76

3.27

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

113

797

1.42

3.25

1.1

9.37

8.10

iu/ml

0.19

226

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

218

1703

1.29

3.23

1.1

14.64

14.01

au/ml

0.05

462

(3034770) Mitochondria Ab [Titer] in Serum

301

2444

1.24

3.23

1.2

1.3

1212.86

955.84

titre

—

101

(1616796) Gas panel - Central venous blood

169

1276

1.33

3.21

3.1

3.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

214

1670

1.29

3.20

1.5

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

783

6920

1.15

3.18

2.7

3.4

35.47

49.16

u/ml

1.50

749

6702

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

349

1.64

3.16

1.4

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

218

1710

1.28

3.14

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

173

2252

0.76

3.11

1.4

1.5

—

(3005033) Fetal Nuchal fold Thickness US

169

2206

0.76

3.10

1.4

1.5

1.17

1.26

2.14

108

1581

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.67

3.08

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1797

16686

1.10

3.07

2.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

202

1.84

3.06

1.7

1.3

119.13

109.37

nmol/l

0.17

145

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

329

1.65

3.06

1.4

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

233

2913

0.79

3.04

1.4

1.5

62.58

60.92

ug/l

0.19

182

2399

(3001019) Free T4 and TSH panel - Serum or Plasma

680

5974

1.15

3.02

1.8

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

295

2411

1.23

3.00

1.3

46.97

42.43

u/ml

0.11

261

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

383

3216

1.20

2.97

2.9

4.0

24.42

24.43

mmol/l

0.01

377

3184

(3020650) Glucose [Presence] in Urine

271

1.70

2.96

1.7

0.07

0.02

estimate

0.28

271

(3003129) Base excess in Capillary blood by calculation

664

1.44

2.91

2.1

1.09

0.99

mmol/l

0.10

640

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

468

4014

1.18

2.86

2.1

3.46

6.48

ug/l

10.78

401

3499

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

305

1.64

2.84

1.1

1.2

—

(3033099) Centromere Ab [Titer] in Serum

245

1.72

2.82

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

221

2752

0.80

2.81

1.4

1.5

0.94

0.95

ratio

0.22

141

1639

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

217

2705

0.80

2.79

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

208

1652

1.27

2.76

1.6

1.7

16023.36

8795.02

e6/l

0.76

141

1167

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

228

1832

1.25

2.74

1.5

1.4

736.85

3816.68

e6/l

0.81

181

1420

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

222

2752

0.80

2.72

1.4

1.5

1.20

1.21

ratio

0.08

143

1650

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

225

1807

1.25

2.72

1.4

1.3

7.27

40.91

e6/l

2.55

164

1316

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

173

1347

1.29

2.70

1.2

5.00

12.54

u/ml

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

111

810

1.38

2.69

1.7

1.6

58.85

51.58

1.06

486

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

357

1.57

2.68

1.3

1.2

0.30

g/l

0.12

285

(3004809) Band form neutrophils/Leukocytes in Blood

130

973

1.34

2.68

2.7

3.1

2.34

1.42

1.27

111

895

(3028679) Herpes simplex virus Ab [Presence] in Serum

494

1.48

2.67

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

222

2745

0.80

2.66

1.4

1.5

1.24

1.15

ratio

0.71

142

1631

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

479

1.49

2.64

1.1

1.2

12.23

19.35

u/l

2.77

434

(3020911) Cortisol [Moles/time] in 24 hour Urine

360

1.56

2.60

1.2

1.4

75.20

199.71

nmol/24h

0.79

360

(3009445) Proteinase 3 Ab [Units/volume] in Serum

344

2902

1.19

2.58

1.5

1.6

36.75

10.57

iu/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

245

1.68

2.55

1.2

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.42

2.53

1.1

23.64

12.20

nmol/l

—

(3021901) Oxygen saturation in Capillary blood

144

1105

1.31

2.52

2.4

2.9

92.00

91.29

0.97

139

1083

(3024891) Influenza virus A+B Ag [Presence] in Specimen

258

2123

1.22

2.52

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

384

3279

1.18

2.52

2.7

3.1

130.12

128.44

g/l

0.88

368

3186

(3007930) Methemoglobin/Hemoglobin.total in Blood

267

2209

1.22

2.48

4.3

4.9

0.87

0.91

0.71

257

2083

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

297

2483

1.20

2.47

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

333

1.57

2.47

1.3

1.2

108.72

111.28

0.29

298

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

496

1.46

2.44

1.3

1.5

4.77

5.61

u/l

1.37

433

(3042733) HLA Ab [Presence] in Serum

191

0.37

2.39

7.7

4.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

482

1.46

2.39

1.1

69.20

74.96

u/l

0.91

437

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

427

0.54

2.38

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

175

1.77

2.37

1.5

1.9

10969.13

26708.21

e6/l

0.51

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

190

1526

1.25

2.35

1.3

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

903

0.68

2.35

2.5

13.60

21.83

iu/ml

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

386

3322

1.17

2.32

2.0

1.8

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

152

1190

1.28

2.32

1.2

1.3

134.55

324.46

titre

1.63

112

(3045716) Anion gap in Serum or Plasma by calculation

585

1.41

2.32

2.4

3.1

10.92

10.79

mmol/l

0.13

572

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

529

1.42

2.27

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

287

2415

1.20

2.26

4.0

4.7

1.54

1.63

0.78

275

2276

(3006184) Hemoglobin [Mass/volume] in Capillary blood

180

1444

1.25

2.26

1.9

2.1

130.89

129.44

g/l

0.46

142

1096

(3023419) Bacteria identified in Sputum by Culture

101

750

1.35

2.25

2.6

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

397

3438

1.16

2.22

1.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

5.56

2.21

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

499

1.43

2.20

1.7

2.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

145

1138

1.28

2.19

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

145

1138

1.28

2.19

1.2

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.41

2.19

1.0

0.03

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

405

3517

1.16

2.19

2.3

—

(3022621) pH of Urine by Test strip

707

6375

1.12

2.16

2.4

2.5

6.04

6.11

1.12

437

4024

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.29

2.15

1.2

1.3

—

(3036180) Methadone [Presence] in Urine

4.29

2.15

1.2

2.6

—

(3042631) Mycobacterium sp identified in Specimen

714

1.35

2.14

2.6

2.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

397

3450

1.16

2.13

2.0

2.2

41.05

40.37

u/l

0.30

367

3155

(3028192) IgG subclass 2 [Mass/volume] in Serum

117

897

1.31

2.12

1.5

1.4

2.88

2.89

g/l

0.02

647

(3024139) IgG subclass 3 [Mass/volume] in Serum

117

898

1.31

2.11

1.5

1.4

0.33

0.38

g/l

1.12

647

(3027135) IgG subclass 1 [Mass/volume] in Serum

117

898

1.31

2.11

1.5

1.4

6.11

6.68

g/l

1.20

647

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

248

2077

1.20

2.08

1.3

432.50

485.92

mg/l

1.26

235

1993

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

103

778

1.33

2.08

1.1

1.2

118.01

115.57

pmol/l

0.18

103

778

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

340

1.50

2.08

1.1

1.0

6.21

11.12

u/ml

1.70

229

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

159

1272

1.25

2.07

1.3

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

489

1.41

2.06

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.00

2.06

0.0

1.2

—

23.69

—

(4062490) Immunoglobulin typing, IgG

114

875

1.31

2.06

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

342

0.53

2.05

1.1

—

(3036489) Thrombin time

329

2833

1.17

2.01

1.6

2.0

19.98

20.58

2.38

273

2434

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

221

1838

1.21

2.01

1.2

3.62

3.65

mmol/l

0.15

210

1744

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

429

0.58

2.01

15.5

13.3

704.08

3811.14

nmol/l

0.52

417

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

442

1.43

2.00

1.4

1.7

3.54

3.04

nmol/l

0.09

351

(4212803) Bone marrow aspirate examination

2.63

2.00

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

158

1270

1.25

1.99

2.3

2.0

0.90

0.86

nmol/l

0.31

136

1086

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

117

907

1.29

1.98

1.2

52.25

59.14

u/l

1.62

107

801

(3044007) Cell count panel - Peritoneal fluid

178

1.69

1.98

1.7

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

554

1.38

1.95

1.4

1.5

6.88

7.17

ug/l

0.11

502

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

270

0.48

1.95

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

175

1427

1.23

1.94

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

279

2379

1.18

1.94

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

488

1.40

1.92

1.4

1.2

58.26

55.52

nmol/l

0.18

483

(3044941) Cell count panel - Synovial fluid

148

1188

1.25

1.90

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

243

1.57

1.89

4.0

4.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

296

2543

1.17

1.88

1.1

4.64

6.72

eliau/ml

0.49

372

(3001964) Herpes simplex virus Ag [Presence] in Specimen

213

1.60

1.84

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

190

1577

1.21

1.80

1.1

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

191

1.63

1.80

1.0

0.51

1.13

u/ml

0.74

165

(3027945) Reticulocytes/Erythrocytes in Blood

693

6312

1.11

1.80

2.3

2.6

1.84

1.80

0.39

618

5641

(3047181) Lactate [Moles/volume] in Blood

207

1733

1.20

1.79

4.8

5.3

1.33

1.24

mmol/l

0.94

184

1532

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

444

1.40

1.79

1.0

1.1

1.73

7.88

u/ml

3.53

(3009214) Lutropin [Units/volume] in Serum or Plasma

257

2194

1.18

1.78

1.2

1.3

14.36

15.33

u/l

0.43

214

1790

(3014111) Lactate [Moles/volume] in Serum or Plasma

565

5093

1.12

1.78

7.4

1.33

1.24

mmol/l

1.14

559

5004

(40761539) Cells [Type] in Urine sediment by Light microscopy

131

1.76

1.77

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

205

1720

1.20

1.74

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

373

0.59

1.73

1.1

1.2

800.00

1031.75

titre

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

265

2275

1.17

1.73

2.0

2.4

167.86

181.98

1.92

245

2163

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1536

14508

1.07

1.70

1.6

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

517

1.36

1.70

1.6

1.9

—

(3004451) EKG impression Narrative

275

1.49

1.68

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

622

1.32

1.67

3.4

3.0

17.23

14.48

index

0.60

347

(3039162) Centromere protein B Ab [Units/volume] in Serum

160

1317

1.22

1.67

1.3

86.02

56.43

u/ml

0.76

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

164

1355

1.21

1.65

1.2

1.1

3.25

2.70

0.25

271

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

563

1.34

1.65

1.1

1.03

1.05

ratio

2.11

464

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.80

1.65

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

685

1.30

1.64

1.3

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

261

2251

1.16

1.63

3.0

25.35

25.51

mmol/l

0.36

250

2175

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

155

1277

1.22

1.62

1.1

126.09

121.16

1.19

139

1155

(3023487) Leukocytes [#/volume] in Peritoneal fluid

205

1.56

1.61

1.6

2.1

6131.16

863.57

e6/l

0.47

128

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

639

5839

1.10

1.58

2.6

2.5

72.49

72.12

ml/min/173m2

0.09

301

2403

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

115

1429

0.80

1.58

1.2

1.4

162.90

154.60

au/ml

0.32

373

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

379

1.40

1.58

1.0

1.1

92.62

93.33

0.06

297

(21494814) CD8 cells/Lymphocytes in Specimen

280

1.47

1.56

1.8

2.3

26.51

29.42

0.79

280

(3024980) IgG subclass 4 [Mass/volume] in Serum

168

1402

1.20

1.55

1.5

0.58

0.62

g/l

0.32

126

1082

(3036071) Salmonella sp Ab [Titer] in Serum

256

1.49

1.54

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.88

1.54

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

632

1.30

1.52

1.5

1.3

4.80

5.01

umol/l

0.21

566

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

205

1746

1.18

1.51

1.2

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.16

1.50

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

250

2165

1.16

1.50

2.2

2.3

10.48

11.17

mg/l

0.77

238

2037

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

182

0.49

1.50

1.2

55.78

68.43

ug/l

—

182

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

147

1216

1.21

1.50

1.2

1.3

0.59

3.30

nmol/l

0.91

141

1178

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

599

1.31

1.49

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

131

1.68

1.49

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

384

1.38

1.48

1.2

1.1

111.21

152.81

iu/ml

1.48

379

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

150

1245

1.21

1.48

1.2

1.3

0.19

0.24

nmol/l

—

(3019977) pH of Arterial blood

702

6470

1.09

1.47

7.6

7.5

7.42

0.30

393

3447

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.81

1.47

1.0

1.1

0.02

0.05

u/ml

1.23

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

352

1.39

1.44

1.9

1.8

1.43

2.54

u/field

1.13

245

(3027801) Oxygen [Partial pressure] in Arterial blood

700

6457

1.09

1.44

7.3

7.4

12.79

13.16

kpa

1.01

679

6231

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

700

6461

1.09

1.42

7.3

7.5

5.12

5.09

kpa

0.29

681

6243

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

204

1.52

1.42

1.1

—

60.20

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

675

1.28

1.41

1.0

0.63

1.63

u/ml

0.88

196

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.82

1.41

4.0

1.2

48.28

59.50

ng/l

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

169

1428

1.19

1.39

1.5

1.8

—

(3017354) Segmented neutrophils/Leukocytes in Blood

625

1.28

1.37

2.9

3.2

57.97

55.41

0.58

558

(3005011) Chlamydia sp Ab [Titer] in Serum

119

1.68

1.37

1.9

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

274

2408

1.14

1.37

2.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

121

0.41

1.37

1.0

1.1

—

1.16

—

(3003396) Base excess in Arterial blood by calculation

693

6408

1.09

1.36

7.4

1.08

0.98

mmol/l

0.27

580

5332

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

122

1002

1.22

1.36

5.0

89.32

117.58

u/ml

0.19

340

(3000991) Gas panel - Venous blood

531

4855

1.10

1.34

8.1

8.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

372

3341

1.12

1.32

6.2

6.7

24.47

24.59

mmol/l

0.31

357

3196

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.00

1.31

0.0

1.1

—

13.71

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

158

1337

1.19

1.30

1.1

—

(3020491) Glucose [Moles/volume] in Blood

498

1.31

1.30

2.0

1.6

6.26

6.34

mmol/l

0.10

367

(3003740) Influenza virus B Ag [Presence] in Specimen

202

1746

1.16

1.29

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

499

1.31

1.28

1.1

2.20

10.13

nmol/l

0.96

(3002619) Bacteria identified in Specimen by Culture

185

1.52

1.28

1.0

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

145

1.59

1.28

1.1

1.5

0.37

0.30

nmol/l

0.29

(40768795) Lymph node Pathology biopsy report

793

1.24

1.27

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

202

1749

1.16

1.26

1.1

—

(4195642) Thrombophilia screening test

151

1279

1.18

1.24

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.40

1.24

1.3

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

250

2203

1.14

1.23

2.0

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

407

1.33

1.22

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

356

1.35

1.21

1.1

1.3

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

106

871

1.22

1.21

1.1

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

305

1.38

1.20

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

620

1.26

1.20

1.4

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

755

1.23

1.19

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

127

1066

1.19

1.17

1.2

1.3

0.16

0.19

nmol/l

0.92

785

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

632

1.25

1.16

1.3

2.01

2.03

mmol/l

0.05

590

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

0.20

—

(3016502) Oxygen saturation in Arterial blood

604

5600

1.08

1.15

7.8

8.0

96.09

96.07

0.02

583

5417

(3028308) Erythrocytes [#/volume] in Pleural fluid

415

0.70

1.14

1.4

5219.53

58246.19

e6/l

1.79

212

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

220

2497

0.88

1.14

1.4

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

132

1556

0.85

1.13

1.2

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

625

1.25

1.13

2.2

4.9

8.61

7.13

mmol/l

0.42

516

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

652

1.24

1.13

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.69

1.13

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

102

842

1.21

1.13

1.1

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

122

1025

1.19

1.13

1.4

1.5

—

2.63

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

102

843

1.21

1.12

1.1

1.2

—

(3024471) HLA-A [Type]

182

0.55

1.09

1.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

129

1093

1.18

1.09

1.1

1.44

1.48

g/l

0.78

115

1000

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

136

1.55

1.08

1.0

1.1

0.01

0.02

u/ml

0.17

(3023199) Leukocytes [#/volume] in Pleural fluid

479

0.73

1.08

1.3

1.4

7389.76

2356.24

e6/l

0.57

327

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

364

1.32

1.07

1.1

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

657

1.24

1.07

1.0

0.68

2.13

u/ml

0.81

146

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

268

2399

1.12

1.06

1.8

2.1

97.00

97.07

0.02

253

2292

(40768441) Liver Pathology biopsy report

631

1.24

1.06

1.3

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

103

858

1.20

1.06

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.92

1.06

1.1

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

170

1.47

1.04

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

633

0.77

1.02

1.4

31.57

35.65

nmol/l

0.46

571

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

136

1582

0.86

1.02

1.2

297.72

267.67

u/ml

0.35

995

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

500

1.26

1.02

1.1

1296.57

1548.88

miu/ml

1.19

500

(3000034) Microalbumin [Mass/volume] in Urine

527

1.25

1.01

2.4

2.7

8.60

39.42

mg/l

1.80

357

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

699

0.79

1.01

1.2

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

635

1.23

1.01

1.1

—

(4281824) Cell count and differential, peritoneal fluid

103

1225

0.84

1.01

1.1

—

(3024932) HLA-DR beta [Type]

177

0.56

1.01

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

230

1.39

1.01

1.0

1.1

20.54

28.49

iu/ml

0.79

230

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

2039

1.13

1.01

1.4

2.2

9.40

10.02

g/l

1.87

202

1839

(3027923) C peptide [Moles/volume] in Serum or Plasma

377

1.30

1.01

1.9

1.28

1.38

nmol/l

0.24

291

(3011048) Pyruvate [Moles/volume] in Blood

1.88

1.00

1.4

93.22

80.60

umol/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

157

1364

1.15

1.00

1.2

4.37

3.66

u/ml

0.29

588

(3045788) Cell count panel - Pleural fluid

403

0.72

1.00

1.2

1.4

—

(4268621) Lupus anticoagulant assay

115

976

1.18

0.98

2.3

2.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

115

976

1.18

0.98

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

131

1124

1.17

0.98

1.1

4491.68

10542.96

iu/ml

0.26

243

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.97

0.0

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

711

1.21

0.97

5.1

6.7

11.43

12.11

mg/l

0.90

672

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

159

1386

1.15

0.97

1.2

2.32

2.84

u/ml

0.31

496

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

272

0.66

0.97

1.7

2.6

105.22

163.11

nmol/l

2.20

243

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

231

2064

1.12

0.97

1.6

2.3

0.42

0.59

g/l

0.49

202

1801

(4027681) Cerebrospinal fluid IgG ratio and IgG index

550

1.24

0.95

1.4

1.2

0.51

0.64

ratio

4.17

316

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

259

1.35

0.94

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

259

1.35

0.94

1.1

1.4

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.89

0.94

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

117

0.51

0.93

1.7

1.6

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

400

1.28

0.93

1.6

1.2

59.50

66.20

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

286

1.33

0.92

1.1

—

(3039000) Anion gap in Blood by calculation

133

1150

1.16

0.92

6.0

6.4

11.18

11.07

mmol/l

0.17

119

1034

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

140

1216

1.15

0.91

1.8

1.7

—

(3018572) Chloride [Moles/volume] in Blood

133

1151

1.16

0.91

6.0

6.4

105.34

105.35

mmol/l

0.01

119

1035

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

120

1031

1.17

0.90

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

331

1.30

0.90

1.4

1.5

13.07

14.14

pmol/l

0.98

274

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

819

1.19

0.90

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

231

0.65

0.89

2.5

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

591

1.22

0.89

1.4

1.5

112557.25

76078.11

e6/l

0.20

390

(3002173) Hemoglobin [Mass/volume] in Arterial blood

575

5386

1.07

0.89

8.3

121.89

119.49

g/l

2.53

564

5262

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

217

2418

0.89

1.7

1.50

1.54

g/l

0.23

186

2075

(3023520) Reticulocytes [#/volume] in Blood

504

4701

1.08

0.88

2.2

2.5

74.79

71.64

e9/l

1.03

374

3356

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

556

1.22

0.88

2.5

2.2

—

(3011412) CD3 cells [#/volume] in Blood

720

1.20

0.88

2.7

2.4

1535.79

1280.24

e6/l

1.42

621

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

511

1.23

0.88

1.5

6.60

6.17

u/l

0.11

412

(3037692) Legionella sp identified in Specimen by Organism specific culture

229

0.65

0.87

1.1

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

476

1.24

0.86

1.6

2.0

1.22

1.20

mmol/l

0.81

471

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

749

1.19

0.86

1.4

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

1.82

0.85

1.5

1.4

—

(3037121) Protein [Mass/volume] in Urine

231

2084

1.11

0.85

2.9

3.1

553.89

365.20

mg/l

0.23

794

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

130

1132

1.15

0.84

1.2

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2374

1.10

0.83

1.5

2.3

3.62

3.63

g/l

0.05

239

2194

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2375

1.10

0.82

1.5

2.3

4.40

4.30

g/l

0.38

239

2192

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.64

0.81

2.5

1.9

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.61

0.81

1.3

2.9

1.56

1.05

mmol/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

250

1.32

0.79

1.3

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

125

1091

1.15

0.79

1.9

2.4

120.17

53.10

ug/min

0.61

649

(3009871) Measles virus Ab [Titer] in Serum

408

0.76

0.79

1.6

1.7

3200.00

3647.74

titre

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

114

1.49

0.79

1.3

1.9

718184.50

274233.36

nmol/l

0.26

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

2381

1.10

0.79

1.5

2.3

7.37

7.39

g/l

0.06

239

2197

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

207

1.35

0.79

1.1

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

813

1.17

0.78

1.2

—

(3024263) Appearance of Synovial fluid

295

1.29

0.78

2.2

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

602

1.20

0.77

1.0

0.15

0.36

u/ml

1.52

132

(3014148) Varicella zoster virus Ab [Titer] in Serum

113

1295

0.87

0.76

1.1

1.2

—

(3006270) Folate [Moles/volume] in Blood

540

1.21

0.75

1.2

1.1

455.37

400.45

nmol/l

1.46

497

(3028717) Thiamine [Mass/volume] in Blood

124

1.45

0.75

1.2

62.44

60.82

ug/l

0.32

124

(3028433) Virus identified in Specimen by Culture

218

1.33

0.74

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.08

0.74

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

144

1277

1.13

0.74

3.7

3.6

674.29

503.33

u/ml

0.12

127

1158

(3032057) Clostridioides difficile [Presence] in Stool

116

1.47

0.74

1.4

1.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.84

0.73

1.0

1.1

0.03

0.05

u/ml

—

(3035285) Chloride [Moles/volume] in Venous blood

487

1.21

0.73

1.6

2.0

106.81

105.43

mmol/l

2.02

482

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

238

2172

1.10

0.73

2.0

2.5

3.66

3.61

g/l

0.20

225

2059

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

249

2278

1.10

0.73

1.5

2.3

2.81

2.85

g/l

0.33

227

2095

(3020630) Protein [Mass/volume] in Serum or Plasma

520

4898

1.07

0.72

2.0

2.6

66.58

66.91

g/l

0.48

480

4547

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

125

1.44

0.72

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

488

1.21

0.72

1.6

2.0

3.96

3.94

mmol/l

0.13

483

(37021550) Renin [Units/volume] in Plasma --upright

142

1.41

0.72

1.2

1.3

171.83

64.47

mu/l

0.50

111

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

344

1.25

0.71

1.7

2.3

123.56

159.33

umol/l

0.33

184

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

701

1.17

0.70

1.2

1.1

267.34

221.83

mg/l

0.38

626

(3029075) Extractable nuclear Ab panel - Serum

618

1.18

0.70

1.1

—

0.36

—

(40768446) Kidney Pathology biopsy report

229

0.70

1.3

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

247

1.30

0.70

1.5

1.7

9.96

8.66

ug/l

1.06

247

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

345

3209

1.08

0.69

9.1

16.30

15.88

2.29

334

3089

(3022493) Free Hemoglobin [Mass/volume] in Plasma

239

1.30

0.68

1.1

4.2

6154.00

707.33

mg/l

0.42

171

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.67

0.68

1.0

1.1

277.77

15.46

pmol/l

—

(40765089) Chromosome analysis panel - Blood by G-banded

204

0.69

0.68

1.0

—

(4034850) Laboratory test

249

2288

1.09

0.68

8.3

8.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

798

1.15

0.67

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

496

0.81

0.67

3.3

3.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

136

1.40

0.66

1.2

1.4

14.04

13.60

g/l

0.06

107

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.59

0.65

6.1

4.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

497

4697

1.06

0.64

5.0

7.2

7.75

8.15

mmol/l

0.83

481

4537

(3006442) Creatine [Moles/volume] in Serum or Plasma

440

1.21

0.64

1.4

67.45

70.31

umol/l

0.71

440

(3012494) Peanut IgE Ab [Units/volume] in Serum

269

1.27

0.63

1.1

0.13

2.35

u/ml

1.91

147

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

212

0.71

0.63

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

121

1.41

0.62

1.0

0.06

0.10

u/ml

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

315

1.24

0.62

2.1

1.9

10.28

9.36

mg/l

0.40

262

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

212

1945

1.09

0.61

2.0

2.1

731.17

451.34

ug/l

0.31

190

1803

(3052592) Norovirus Ag [Presence] in Stool

104

0.58

0.61

1.0

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

173

1.33

0.61

1.3

35.61

38.82

g/l

0.96

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

388

1.21

0.61

1.4

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.48

0.60

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.60

0.0

6.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

108

957

1.13

0.60

1.1

98.74

96.81

0.32

103

900

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

667

1.16

0.59

1.2

1.0

289.04

302.30

mg/l

1.17

599

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.58

0.0

1.8

—

0.53

—

(3024928) Oxygen saturation in Venous blood

153

1387

1.11

0.58

2.0

3.3

60.68

62.33

0.41

148

1350

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

1.32

0.58

9.6

3.9

11.86

10.66

kpa

0.69

175

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

175

1.32

0.58

9.6

3.9

4.85

4.90

kpa

0.09

175

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

716

1.15

0.57

1.2

1.1

41.53

38.60

mg/l

0.10

607

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

493

1.18

0.57

2.0

1.88

2.21

u/field

0.29

267

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

217

2003

1.09

0.56

1.9

2.0

1.14

1.94

ug/l

1.12

188

1791

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

184

0.71

0.56

1.0

1.2

7.60

9.42

pmol/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

238

1.26

0.56

1.4

2.0

40.30

40.95

g/l

0.25

238

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

341

0.79

0.55

1.1

—

0.13

—

(4015189) Microbial culture of sputum

124

1.37

0.55

2.1

2.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.62

0.55

1.2

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

104

926

1.12

0.55

1.1

—

1.31

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

107

1.40

0.55

1.3

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

296

0.78

0.55

1.0

1.2

—

0.22

g/l

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

239

1.26

0.55

1.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

239

1.26

0.55

1.3

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

449

1.18

0.54

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

168

1.31

0.54

1.2

1.4

48.08

43.48

0.16

113

(3016650) Hepatitis A virus Ab [Presence] in Serum

145

1317

1.10

0.54

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.58

0.54

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.58

0.54

1.2

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

142

1.34

0.54

1.2

1.7

—

1.49

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

293

2743

1.07

0.54

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

186

1.29

0.54

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

186

1.29

0.54

1.1

—

(3014271) Vancomycin [Susceptibility]

178

1.29

0.52

2.3

2.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

143

1302

1.10

0.52

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

424

1.18

0.52

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

326

0.80

0.51

1.3

1.5

11.35

12.67

u/l

0.68

318

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

100

0.60

0.51

2.7

7.4

5.42

5.77

kpa

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

100

894

1.12

0.51

5.2

5.8

345.45

379.90

umol/l

1.95

783

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

462

1.17

0.51

1.3

1.5

15.40

22.61

u/ml

—

(3025130) Human papilloma virus identified in Specimen

237

2209

1.08

0.50

1.7

1.8

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

191

0.73

0.50

1.0

5.04

5.89

mg/g

0.65

181

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1594

1.09

0.49

1.5

2.3

0.00

g/l

-0.00

160

1499

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

185

1710

1.08

0.49

1.5

2.2

0.00

g/l

0.65

161

1503

(44806071) Cardiolipin IgM antibody measurement

136

1.32

0.49

1.0

1.1

—

(3001729) Color of Synovial fluid

1.56

0.48

2.3

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.40

0.48

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.45

0.48

2.5

2.8

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

102

1.37

0.47

1.0

1.1

—

33.28

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

513

1.15

0.46

2.6

2.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

532

1.15

0.46

1.1

—

(3012441) Differential panel - Pleural fluid

397

0.83

0.46

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

440

0.84

0.46

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.38

0.45

1.2

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.61

0.45

1.0

—

4.33

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

129

1.32

0.45

1.2

1.4

34.32

26.30

g/l

0.95

(3026051) Granulocytes/Leukocytes in Pleural fluid

0.60

0.45

1.8

1.4

5.60

19.96

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

284

2678

1.06

0.45

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

329

1.19

0.44

1.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

329

1.19

0.44

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

329

1.19

0.44

1.5

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

329

1.19

0.44

1.5

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

112

1.34

0.44

1.2

1.3

6.01

5.78

mmol/l

0.46

112

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

404

1.16

0.44

1.0

310.65

340.28

ng/l

0.33

301

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

526

1.14

0.43

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

526

1.14

0.43

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

526

1.14

0.43

1.5

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

162

1502

1.08

0.42

2.6

3.3

0.33

0.38

iu/ml

1.02

831

(3035320) C reactive protein [Mass/volume] in Body fluid

617

0.87

0.42

3.2

2.7

37.46

23.01

mg/l

1.51

441

(40765096) Chromosome analysis panel by Banding

162

0.74

0.42

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.64

0.42

2.7

7.5

5.87

5.96

kpa

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

135

1465

0.92

0.42

4.1

5.5

2627.75

459.80

iu/ml

0.53

185

(3020393) Adenovirus Ag [Presence] in Stool

1.43

0.41

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

316

0.82

0.41

2.3

3.2

9.83

8.59

mg/l

0.42

250

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.41

0.0

1.0

—

3.67

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.41

0.0

1.6

—

4.24

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.0

—

15.33

—

(3022670) pH of Venous cord blood

0.00

0.41

0.0

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.41

0.0

1.1

—

66.16

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

407

1.16

0.41

1.0

37.96

40.96

ng/l

0.20

298

(40768806) Pleura Pathology biopsy report

423

0.85

0.40

1.3

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

193

1807

1.07

0.40

2.5

3.2

35.59

34.38

mg/l

0.09

150

1540

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

113

1036

1.09

0.39

1.1

1.2

0.43

1.09

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

512

1.13

0.39

1.3

1.0

1.24

1.12

u/l

0.58

203

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.41

0.39

2.7

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

193

1809

1.07

0.39

2.5

3.2

35.47

70.20

mg/l

0.61

150

1544

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

242

1.20

0.38

1.3

1.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

192

1801

1.07

0.38

2.5

2.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.39

0.38

3.0

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

191

1792

1.07

0.38

1.5

2.2

0.04

0.01

g/l

0.38

172

1621

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

298

1.18

0.38

1.1

—

3.79

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

1.35

0.37

1.0

0.02

0.22

u/ml

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

214

0.79

0.37

1.4

2.2

1.34

3.72

ug/l

—

129

(3035611) Eosinophils/Leukocytes in Synovial fluid

1.35

0.37

2.8

1.6

0.38

0.17

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.30

0.37

1.2

1.1

124.44

83.94

titre

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

893

0.91

0.37

1.7

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

125

1.28

0.36

1.8

1.7

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.29

0.36

2.9

2.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.36

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

544

1.12

0.36

1.2

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

207

1.21

0.36

1.0

1.1

—

(21494755) Public health laboratory ask at order entry panel

867

8904

0.97

0.36

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

272

1.18

0.36

1.8

1.2

28.67

18.47

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.33

0.35

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.33

0.35

2.5

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

263

1.18

0.35

3.2

1.9

0.12

0.19

e9/l

1.21

117

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

226

1.20

0.35

2.5

3.3

28.01

27.74

umol/l

0.05

172

(3042517) Benzodiazepines panel - Urine

1.31

0.35

1.5

2.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

319

3048

1.05

0.35

1.4

1.5

105.05

131.28

pmol/l

0.72

308

2976

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

385

1.14

0.35

1.3

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.40

0.35

1.5

1.3

23.17

75.71

u/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

190

1.21

0.34

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

405

1.14

0.34

1.0

875.74

760.46

ng/l

0.75

293

(1761482) Bacteria [#/volume] in Urine by Culture

133

1239

1.07

0.34

4.8

3.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

626

0.89

0.34

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.33

0.33

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

191

1.20

0.33

1.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

182

1.21

0.33

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.68

0.33

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

164

1.22

0.32

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

169

1591

1.06

0.32

2.4

3.1

1.41

2.54

ratio

2.85

894

(3041672) Baker's yeast Ab [Presence] in Serum

1.28

0.32

1.0

—

(3019174) dRVVT (LA screen)

1.33

0.32

1.2

—

(4133840) Spirometry

165

0.79

0.32

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

184

1946

0.94

0.31

2.8

3.1

1.39

1.37

mg/l

0.15

167

1800

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.35

0.31

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

165

1.21

0.31

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

197

0.81

0.31

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

290

2777

1.05

0.31

1.6

1.5

94.51

0.20

iu/ml

0.51

477

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

222

2112

1.05

0.30

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

221

1.18

0.30

2.4

2.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.30

0.30

1.0

—

504.40

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

128

1200

1.07

0.29

1.3

1.4

7.01

7.04

mmol/l

0.05

123

1076

(3023410) Appearance of Cerebral spinal fluid

852

1.08

0.29

1.4

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

307

1.14

0.28

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

167

1.20

0.28

1.2

—

(3017569) Oxygen content in Arterial blood

259

0.85

0.28

2.0

2.2

16.50

15.80

0.55

259

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.32

0.28

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.30

0.26

1.0

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

0.68

0.26

1.2

1.9

16.76

14.67

ml/dl

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

592

0.91

0.25

2.4

3.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

559

1.09

0.25

3.4

2.5

207.82

218.93

e6/l

0.19

464

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

151

1.19

0.25

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

151

1.19

0.25

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

151

1.19

0.25

1.2

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.20

0.25

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

705

0.92

0.24

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

223

0.85

0.24

3.5

2.6

0.62

0.61

mmol/l

0.10

223

(3044009) aPTT.lupus sensitive (LA screen)

1.28

0.24

1.1

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

180

1719

1.05

0.24

4.1

3.9

1.26

1.34

mmol/l

0.66

175

1691

(3000330) Specific gravity of Urine by Test strip

346

3351

1.03

0.23

3.6

3.0

1.02

ratio

0.06

310

2975

(3020876) Protein [Mass/time] in 24 hour Urine

629

1.08

0.23

2.5

2.4

1.08

1.04

g/24h

0.04

347

(3044242) Glucose [Moles/volume] in Arterial blood

265

1.13

0.23

3.3

1.8

7.89

8.17

mmol/l

0.19

265

(3035637) Corticotropin [Mass/volume] in Plasma

110

1037

1.06

0.23

1.6

36.83

26.81

ng/l

0.37

110

1031

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

370

1.11

0.23

3.1

2.8

48.38

44.63

0.56

223

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

162

1.17

0.22

1.1

1.2

251.77

361.25

pmol/l

0.86

122

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.77

0.22

1.6

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

959

9756

0.98

0.22

1.8

1.7

—

(3034426) Prothrombin time (PT)

257

1.13

0.22

1.3

1.2

27.10

27.96

0.66

257

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

632

1.08

0.21

7.3

6.8

11.97

62.77

ug/l

1.09

405

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

210

1.14

0.21

1.8

2.2

18.25

16.27

umol/l

0.30

210

(3044927) Protein electrophoresis panel - Urine

497

1.09

0.21

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

229

1.14

0.21

1.0

1.2

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.22

0.21

1.0

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

527

1.08

0.21

3.1

2.3

481.87

516.64

e6/l

0.33

413

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.25

0.20

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.22

0.20

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

174

1.15

0.19

1.1

1.0

13.01

7.00

u/ml

0.75

174

(3036782) Glucose [Moles/volume] in Pleural fluid

437

0.91

0.19

1.1

1.3

6.18

6.21

mmol/l

0.04

408

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.15

0.19

3.2

1.6

50.33

46.42

umol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.15

0.19

1.0

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

841

1.06

0.19

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

841

1.06

0.19

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

841

1.06

0.19

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

841

1.06

0.19

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

376

1.09

0.18

1.1

—

(4198724) Urine methamphetamine measurement

309

1.10

0.18

1.3

2.6

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

119

1.18

0.17

1.1

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.11

0.17

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.76

0.17

2.0

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

894

1.05

0.17

1.2

24.11

25.02

u/l

0.04

779

(3023183) Ammonium ion [Moles/volume] in Plasma

110

1151

0.96

0.17

2.7

2.8

33.22

32.75

umol/l

0.09

1056

(3017817) Protein [Mass] in Urine collected for unspecified duration

456

1.08

0.16

2.5

2.6

1682.24

849.51

1.21

451

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

719

1.06

0.16

1.2

1.1

19.76

16.94

u/ml

0.35

324

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

162

0.86

0.16

2.0

1.6

131.76

40.51

u/l

0.34

146

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.13

0.16

2.3

1.5

77.38

122.97

ug/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

139

1338

1.04

0.16

3.6

3.4

20.56

23.75

mg/l

0.60

906

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

156

1616

0.96

0.15

1.3

1.4

2.22

3.71

ug/l

4.19

125

1396

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

140

0.86

0.15

1.0

1.3

1.19

1.18

mmol/l

0.04

140

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.13

0.15

1.2

2.4

0.44

0.76

u/field

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

663

1.06

0.15

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

140

1.14

0.15

1.1

1.3

100.28

49.24

mg/l

0.19

105

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.10

0.15

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

287

2939

0.98

0.14

2.2

2.1

3.84

16.43

iu/l

1.13

121

1307

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.81

0.14

1.3

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

103

1.17

0.13

1.0

0.12

0.57

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

170

0.88

0.13

1.7

2.6

—

(3017704) Immunofixation for Urine

247

1.09

0.13

1.6

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

238

2322

1.03

0.13

2.7

3.5

630.19

501.98

u/ml

0.13

202

1983

(3003181) Sodium [Moles/volume] in Urine

115

1111

1.04

0.12

1.4

60.21

63.44

mmol/l

0.39

873

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

522

1.05

0.12

1.2

13.24

23.84

u/l

1.69

438

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

168

0.89

0.11

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

298

1.07

0.11

1.2

1.5

0.53

0.50

e9/l

0.31

298

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

240

0.92

0.11

1.1

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

486

0.95

0.11

1.5

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

239

0.92

0.10

1.5

1.6

0.54

0.41

ug/l

0.65

174

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

881

0.96

0.10

1.1

—

88.43

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

728

0.96

0.10

3.5

3.3

0.76

0.80

nmol/l

0.57

573

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.11

0.09

1.0

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

802

7948

1.01

0.09

1.7

1.6

3.55

3.51

mmol/l

0.52

563

5314

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1058

10501

1.01

0.09

2.0

1.9

3.43

3.27

ratio

4.98

820

7812

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

686

1.04

0.08

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.81

0.08

1.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.82

0.07

1.0

0.01

0.14

u/ml

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

266

0.94

0.07

1.4

2.2

0.82

1.22

ug/l

1.22

253

(3024869) Neuronal Ab [Presence] in Serum

108

1.11

0.07

1.2

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

531

1.04

0.07

1.2

67.43

84.97

u/l

1.69

462

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.85

0.06

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

224

0.94

0.06

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

224

0.94

0.06

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

224

0.94

0.06

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

224

0.94

0.06

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

148

1.08

0.06

1.1

0.60

0.61

umol/24h

—

(3045142) Bone marrow Pathology biopsy report

649

0.97

0.06

1.2

1.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

276

1.05

0.06

2.1

3.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

227

1.06

0.06

2.8

3.3

1.81

1.46

0.36

227

(21494434) Karyotype in Bone marrow

456

0.96

0.05

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

662

6577

1.01

0.05

3.6

4.3

226.75

240.19

u/l

2.63

624

6248

(3034274) Bile acid [Moles/volume] in Serum --fasting

138

1357

1.02

0.05

1.6

2.2

4.57

6.00

umol/l

1.80

993

(3008295) Osmolality of Serum or Plasma

728

0.98

0.05

1.4

1.5

280.13

277.88

mosm/kgh2o

0.43

564

(3000012) Reticulocyte production index

673

1.03

0.05

2.1

2.0

0.96

0.91

0.19

408

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

110

1.09

0.05

1.0

0.01

0.21

u/ml

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

110

1.09

0.05

1.0

0.01

0.02

u/ml

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

242

0.95

0.05

2.6

3.6

252.95

82.52

ng/l

0.38

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

181

0.94

0.05

1.4

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

676

0.98

0.04

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

454

0.97

0.04

1.7

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

144

1420

1.01

0.04

1.1

3.93

3.37

eliau/ml

0.19

739

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

826

0.98

0.04

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

477

1.03

0.04

1.3

1.2

11.37

9.93

mm/h

0.33

477

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

323

3254

0.99

0.04

1.1

0.56

0.59

ratio

0.73

397

(4211845) Urine protein measurement

369

1.03

0.03

4.1

3.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

471

0.98

0.03

1.1

1.2

—

2398.51

—

(3004775) Volume in Urine collected for unspecified duration

349

0.97

0.02

1.8

2.4

619.65

631.46

0.06

259

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

1.04

0.02

1.1

—

(3022689) Creatine [Moles/volume] in Urine

232

1.03

0.02

1.4

1.5

7.54

7.32

mmol/l

0.11

232

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

651

1.01

0.01

1.5

1.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

127

0.94

0.01

3.9

2.0

4.08

10.07

ug/l

0.95

127

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

831

1.01

0.01

1.2

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

287

0.98

0.01

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

493

1.01

0.01

1.1

1.6

1.03

1.14

promille

0.24

379

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

104

1.06

0.01

1.2

1.9

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

114

1.05

0.00

1.1

1.0

0.09

0.83

u/ml

—

(3037756) Immunofixation for Serum or Plasma

107

1077

0.99

0.00

1.9

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

166

0.96

0.00

1.2

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

556

0.99

0.00

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

113

0.97

0.00

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

477

1.01

0.00

1.5

1.7

2.52

1.47

u/ml

0.56

120

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

224

0.98

0.00

1.8

2.0

9.33

96.24

ug/min

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

627

1.00

0.00

1.2

140.00

189.57

titre

0.25

115

(3006462) Nitrate [Presence] in Urine

334

0.99

0.00

4.5

3.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

344

0.99

0.00

2.1

2.2

63.89

60.11

ug/l

0.13

337

(21494890) Protein electrophoresis panel - 24 hour Urine

514

0.99

0.00

2.1

2.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

315

1.02

0.00

1.1

1.2

80.16

56.53

u/ml

0.78

308

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

118

1.02

0.00

1.0

1.6

—

6959.09

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

262

0.99

0.00

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

262

0.99

0.00

1.4

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

6369

63695

1.00

0.00

19.2

16.9

331.41

331.10

g/l

2.41

6337

63385

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

139

1.01

0.00

1.1

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

0.00

0.0

1.4

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1567.78

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

100

1.00

-0.00

3.3

1.9

1.74

1.60

mg/l

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.94

-0.00

1.0

1.1

—

18.13

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.93

-0.00

3.6

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.95

-0.00

2.1

2.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.01

-0.00

2.1

2.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.00

-0.00

1.7

1.6

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.93

-0.00

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

327.80

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

34.47

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.97

-0.00

1.1

1.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

22.43

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.97

-0.00

1.0

1.1

1.90

1.56

umol/24h

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.6

—

2.60

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.88

-0.00

1.8

1.5

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.97

-0.00

2.0

2.8

19.17

35.66

mg/mmol

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.88

-0.00

1.0

1.1

9.80

12.05

u/l

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

180

1.00

-0.00

1.1

1.0

4.36

1.06

u/ml

—

110

(3008536) Aspergillus sp Ab [Presence] in Serum

110

1.00

-0.00

1.5

2.2

—

(3022475) Manganese [Moles/volume] in Blood

0.94

-0.00

1.0

1.2

0.14

0.16

umol/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.86

-0.00

1.4

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_HYPERTROPHYBREAST and mortality.

Females

Parameter	HR [95% CI]	p-value
N14_HYPERTROPHYBREAST	0.949 [0.84, 1.07]	0.41
Birth year	0.995 [0.99, 1.0]	0.267

During the follow-up period (1.1.1998 — 31.12.2019), 1086 out of 28911 females with N14_HYPERTROPHYBREAST died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have N14_HYPERTROPHYBREAST.

N-year risk	Females	Males
1	0.095%	No data
5	0.545%	No data
10	1.349%	No data
15	2.61%	No data
20	4.718%	No data

Relationships between endpoints

↥

Index endpoint: N14_HYPERTROPHYBREAST – Hypertrophy of breast

GWS hits: 41

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypertrophy of breast

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints